Miguel Ángel González‐gay

Miguel Ángel González‐gay's AcademicInfluence.com Rankings

Biology

#7820

World Rank

#10795

Historical Rank

Genetics

#757

World Rank

#849

Historical Rank

Neuroscience

#1042

World Rank

#1084

Historical Rank

biology Degrees

Download Badge

Biology

Miguel Ángel González‐gay's Degrees

PhD Genetics Complutense University of Madrid
Masters Biology Complutense University of Madrid
Bachelors Biotechnology Complutense University of Madrid

Similar Degrees You Can Earn

Best Online Master's in Biology

Why Is Miguel Ángel González‐gay Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Miguel Ángel González‐gay's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Genetics of rheumatoid arthritis contributes to biology and drug discovery (2013) (1877)
EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis (2009) (1304)
EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update (2016) (865)
Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci (2013) (689)
High density genetic mapping identifies new susceptibility loci for rheumatoid arthritis (2012) (595)
Epidemiology of giant cell arteritis and polymyalgia rheumatica. (2009) (471)
Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus (2010) (377)
HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis. (2007) (376)
Rheumatoid arthritis: a disease associated with accelerated atherogenesis. (2005) (361)
Association of a functional single-nucleotide polymorphism of PTPN22, encoding lymphoid protein phosphatase, with rheumatoid arthritis and systemic lupus erythematosus. (2005) (342)
Leptin in the interplay of inflammation, metabolism and immune system disorders (2017) (328)
High-grade C-reactive protein elevation correlates with accelerated atherogenesis in patients with rheumatoid arthritis. (2005) (283)
Increased Prevalence of Severe Subclinical Atherosclerotic Findings in Long-Term Treated Rheumatoid Arthritis Patients Without Clinically Evident Atherosclerotic Disease (2003) (266)
High prevalence of subclinical atherosclerosis in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors. (2007) (256)
Obesity, Fat Mass and Immune System: Role for Leptin (2018) (252)
Active but transient improvement of endothelial function in rheumatoid arthritis patients undergoing long-term treatment with anti-tumor necrosis factor alpha antibody. (2004) (249)
Carotid intima-media thickness predicts the development of cardiovascular events in patients with rheumatoid arthritis. (2009) (231)
Biopsy-negative giant cell arteritis: clinical spectrum and predictive factors for positive temporal artery biopsy. (2001) (230)
Major histocompatibility complex associations of ankylosing spondylitis are complex and involve further epistasis with ERAP1 (2015) (214)
Carotid ultrasound is useful for the cardiovascular risk stratification of patients with rheumatoid arthritis: results of a population-based study (2013) (212)
Endothelial dysfunction in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors. (2007) (212)
Aortic Aneurysm and Dissection in Patients With Biopsy-Proven Giant Cell Arteritis From Northwestern Spain: A Population-Based Study (2004) (211)
Strokes at Time of Disease Diagnosis in a Series of 287 Patients With Biopsy-Proven Giant Cell Arteritis (2009) (205)
Henoch-Schönlein purpura in children and adults: clinical differences in a defined population. (2002) (204)
The epidemiology of the primary systemic vasculitides in northwest Spain: implications of the Chapel Hill Consensus Conference definitions. (2003) (203)
Anti-tumor necrosis factor-alpha blockade improves insulin resistance in patients with rheumatoid arthritis. (2006) (197)
Could HLA-DRB1 be the protective locus in rheumatoid arthritis? (1995) (191)
HLA-DRB1 status affects endothelial function in treated patients with rheumatoid arthritis. (2003) (186)
Giant Cell Arteritis in Northwestern Spain: A 25-Year Epidemiologic Study (2007) (178)
Influence of Traditional Risk Factors of Atherosclerosis in the Development of Severe Ischemic Complications in Giant Cell Arteritis (2004) (178)
Immunochip analysis identifies multiple susceptibility loci for systemic sclerosis. (2014) (177)
Rheumatoid arthritis and metabolic syndrome (2014) (170)
Impact of risk factors associated with cardiovascular outcomes in patients with rheumatoid arthritis (2017) (169)
Epidemiology of the vasculitides. (2001) (167)
Fine mapping seronegative and seropositive rheumatoid arthritis to shared and distinct HLA alleles by adjusting for the effects of heterogeneity. (2014) (167)
Identification of Novel Genetic Markers Associated with Clinical Phenotypes of Systemic Sclerosis through a Genome-Wide Association Strategy (2011) (158)
Genetic markers of disease susceptibility and severity in giant cell arteritis and polymyalgia rheumatica. (2003) (156)
Protection against anti-citrullinated protein antibody-positive rheumatoid arthritis is predominantly associated with HLA-DRB1*1301: a meta-analysis of HLA-DRB1 associations with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in fou (2010) (151)
The High Prevalence of Subclinical Atherosclerosis in Patients With Ankylosing Spondylitis Without Clinically Evident Cardiovascular Disease (2009) (144)
Critical role of interleukin (IL)-17 in inflammatory and immune disorders: An updated review of the evidence focusing in controversies. (2019) (141)
Insulin resistance in rheumatoid arthritis: the impact of the anti‐TNF‐α therapy (2010) (140)
Association of the C8orf13-BLK region with systemic sclerosis in North-American and European populations. (2010) (139)
Validated methods for assessment of subclinical atherosclerosis in rheumatology (2012) (135)
A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibility. (2015) (133)
Cardiovascular risk stratification in rheumatic diseases: carotid ultrasound is more sensitive than Coronary Artery Calcification Score to detect subclinical atherosclerosis in patients with rheumatoid arthritis (2013) (131)
Giant cell arteritis: disease patterns of clinical presentation in a series of 240 patients. (2006) (131)
Carotid intima media thickness in rheumatoid arthritis as compared to control subjects: a meta-analysis. (2011) (130)
Correlation between endothelial function and carotid atherosclerosis in rheumatoid arthritis patients with long-standing disease (2011) (130)
Epidemiology of biopsy proven giant cell arteritis in northwestern Spain: trend over an 18 year period (2001) (130)
TNFA -308 (rs1800629) polymorphism is associated with a higher risk of cardiovascular disease in patients with rheumatoid arthritis. (2011) (129)
Clinical Spectrum Time Course in Anti Jo-1 Positive Antisynthetase Syndrome (2015) (128)
Relapses and Recurrences in Giant Cell Arteritis: A Population-Based Study of Patients With Biopsy-Proven Disease From Northwestern Spain (2011) (127)
Echocardiographic and Doppler findings in long-term treated rheumatoid arthritis patients without clinically evident cardiovascular disease. (2004) (124)
A loss-of-function variant of PTPN22 is associated with reduced risk of systemic lupus erythematosus. (2008) (124)
Systemic Sclerosis in Northwestern Spain: A 19-year Epidemiologic Study (2008) (124)
Tocilizumab in giant cell arteritis: Multicenter open-label study of 22 patients. (2015) (121)
Metabolic Syndrome in Rheumatoid Arthritis (2013) (120)
Association of STAT4 with rheumatoid arthritis: a replication study in three European populations. (2008) (118)
Cardiovascular Safety During Treatment With Baricitinib in Rheumatoid Arthritis (2019) (116)
Short-term improvement of endothelial function in rituximab-treated rheumatoid arthritis patients refractory to tumor necrosis factor alpha blocker therapy. (2008) (115)
Cardiovascular risk assessment in patients with rheumatoid arthritis: The relevance of clinical, genetic and serological markers. (2016) (115)
Endothelial dysfunction, carotid intima-media thickness, and accelerated atherosclerosis in rheumatoid arthritis. (2008) (114)
Abatacept in patients with rheumatoid arthritis and interstitial lung disease: A national multicenter study of 63 patients. (2018) (113)
Cardiovascular magnetic resonance in rheumatology: Current status and recommendations for use. (2016) (112)
Cardiovascular safety findings in patients with rheumatoid arthritis treated with tofacitinib, an oral Janus kinase inhibitor. (2016) (111)
Effect of anti-tumor necrosis factor alpha therapy on the progression of subclinical atherosclerosis in severe rheumatoid arthritis. (2006) (108)
Influence of anti-TNF-alpha infliximab therapy on adhesion molecules associated with atherogenesis in patients with rheumatoid arthritis. (2006) (107)
High-density genotyping of immune loci in Koreans and Europeans identifies eight new rheumatoid arthritis risk loci. (2015) (106)
Adipokines: Linking metabolic syndrome, the immune system, and arthritic diseases. (2019) (102)
Adipokines and inflammation: is it a question of weight? (2018) (102)
Rheumatic Manifestations of Infective Endocarditis in Non-Addicts: A 12-Year Study (2001) (102)
Cardiovascular morbidity and associated risk factors in Spanish patients with chronic inflammatory rheumatic diseases attending rheumatology clinics: Baseline data of the CARMA Project. (2015) (101)
A functional variant of vascular endothelial growth factor is associated with severe ischemic complications in giant cell arteritis. (2005) (101)
Evidence of association of macrophage migration inhibitory factor gene polymorphisms with systemic lupus erythematosus (2006) (101)
A systemic sclerosis and systemic lupus erythematosus pan-meta-GWAS reveals new shared susceptibility loci. (2013) (99)
Temporal arteritis in a northwestern area of Spain: study of 57 biopsy proven patients. (1992) (97)
Can suppression of inflammation by anti-TNF prevent progression of subclinical atherosclerosis in inflammatory arthritis? (2014) (96)
Cardiovascular disease in inflammatory rheumatic diseases. (2016) (96)
A1298C polymorphism in the MTHFR gene predisposes to cardiovascular risk in rheumatoid arthritis (2010) (92)
Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course (2019) (89)
Giant Cell Arteritis: Epidemiology, Diagnosis, and Management (2010) (88)
Efficacy of Anakinra in Refractory Adult-Onset Still's Disease (2015) (88)
Inducible but not endothelial nitric oxide synthase polymorphism is associated with susceptibility to rheumatoid arthritis in northwest Spain. (2004) (87)
Association of giant cell arteritis and polymyalgia rheumatica with different tumor necrosis factor microsatellite polymorphisms. (2000) (87)
Identification of CSK as a systemic sclerosis genetic risk factor through Genome Wide Association Study follow-up. (2012) (87)
ERAP2 is associated with ankylosing spondylitis in HLA-B27-positive and HLA-B27-negative patients (2015) (86)
Adult-onset Still's disease: Advances in the treatment. (2016) (85)
Anti-TNF-alpha therapy modulates resistin in patients with rheumatoid arthritis. (2008) (83)
Effects of tofacitinib and other DMARDs on lipid profiles in rheumatoid arthritis: implications for the rheumatologist. (2016) (83)
Tocilizumab in refractory aortitis: study on 16 patients and literature review. (2014) (83)
Audiovestibular Manifestations in Giant Cell Arteritis: A Prospective Study (2003) (82)
Inflammation and lipid profile in rheumatoid arthritis: bridging an apparent paradox (2014) (81)
Recommendations for the treatment of anti-melanoma differentiation-associated gene 5-positive dermatomyositis-associated rapidly progressive interstitial lung disease. (2020) (81)
NFKB1-94ATTG ins/del polymorphism (rs28362491) is associated with cardiovascular disease in patients with rheumatoid arthritis. (2012) (80)
The PTPN22 R263Q polymorphism is a risk factor for rheumatoid arthritis in Caucasian case-control samples. (2011) (80)
Association of ferritin autoantibodies with giant cell arteritis/polymyalgia rheumatica (2012) (79)
Analysis of a functional BTNL2 polymorphism in type 1 diabetes, rheumatoid arthritis, and systemic lupus erythematosus. (2005) (79)
HLA-DRB1 alleles encoding an aspartic acid at position 70 protect against development of rheumatoid arthritis. (2001) (78)
Prevalence of hepatitis C serum antibody in autoimmune diseases. (2009) (77)
A genome-wide association study of rheumatoid arthritis without antibodies against citrullinated peptides (2013) (77)
Anti-TNF-α therapy in refractory uveitis associated with sarcoidosis: Multicenter study of 17 patients. (2015) (77)
HO-1 promoter polymorphism associated with rheumatoid arthritis. (2007) (76)
Recommendations for the management of cardiovascular risk in patients with rheumatoid arthritis: scientific evidence and expert opinion. (2014) (76)
Interleukin 1 receptor antagonist gene polymorphism is associated with severe renal involvement and renal sequelae in Henoch-Schönlein purpura. (2002) (76)
Polymyalgia rheumatica (2017) (75)
Listeria monocytogenes infection in patients with rheumatic diseases on TNF-alpha antagonist therapy: the Spanish Study Group experience. (2008) (74)
Henoch-Schönlein Purpura in Northern Spain Clinical Spectrum of the Disease in 417 Patients From a Single Center (2014) (74)
Different gene loci within the HLA-DR and TNF regions are independently associated with susceptibility and severity in Spanish rheumatoid arthritis patients. (2000) (74)
Biomechanics, obesity, and osteoarthritis. The role of adipokines: When the levee breaks (2017) (74)
A replication study confirms the association of TNFSF4 (OX40L) polymorphisms with Systemic Sclerosis in a large European cohort (2010) (73)
Interleukin 8 gene polymorphism is associated with increased risk of nephritis in cutaneous vasculitis. (2002) (73)
Molecular Relationships among Obesity, Inflammation and Intervertebral Disc Degeneration: Are Adipokines the Common Link? (2019) (70)
Henoch-Schönlein Purpura in Northern Spain (2014) (70)
Protective role of major histocompatibility complex class II Ebd transgene on collagen-induced arthritis (1994) (69)
Giant cell arteritis: laboratory tests at the time of diagnosis in a series of 240 patients. (2006) (68)
Genetics of immunoglobulin-A vasculitis (Henoch-Schönlein purpura): An updated review. (2018) (68)
Genetic epidemiology: Giant cell arteritis and polymyalgia rheumatica (2001) (68)
Correction: Identification of Novel Genetic Markers Associated with Clinical Phenotypes of Systemic Sclerosis through a Genome-Wide Association Strategy (2011) (67)
The Spectrum of Paraneoplastic Cutaneous Vasculitis in a Defined Population (2013) (66)
Anti-IL6-Receptor Tocilizumab in Refractory and Noninfectious Uveitic Cystoid Macular Edema: Multicenter Study of 25 Patients. (2019) (65)
Tocilizumab in giant cell arteritis. Observational, open-label multicenter study of 134 patients in clinical practice. (2019) (65)
Progranulin as a biomarker and potential therapeutic agent. (2017) (65)
Systemic Lupus Erythematosus in Northwestern Spain: A 20-Year Epidemiologic Study (2011) (64)
The erythrocyte sedimentation rate is associated with the development of visual complications in biopsy-proven giant cell arteritis. (2008) (64)
Visfatin is not associated with inflammation or metabolic syndrome in patients with severe rheumatoid arthritis undergoing anti-TNF-alpha therapy. (2010) (63)
Interferon-gamma gene microsatellite polymorphisms in patients with biopsy-proven giant cell arteritis and isolated polymyalgia rheumatica. (2004) (63)
Integrative Analysis Reveals a Molecular Stratification of Systemic Autoimmune Diseases (2020) (63)
Confirmation of TNIP1 but not RHOB and PSORS1C1 as systemic sclerosis risk factors in a large independent replication study (2012) (62)
Interleukin-6 gene -174 promoter polymorphism is associated with endothelial dysfunction but not with disease susceptibility in patients with rheumatoid arthritis. (2009) (62)
Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group (2017) (62)
Meta-analysis of Immunochip data of four autoimmune diseases reveals novel single-disease and cross-phenotype associations (2018) (62)
Anti-TNF-α therapy does not modulate leptin in patients with severe rheumatoid arthritis (2009) (62)
Analysis of IRF5 gene functional polymorphisms in rheumatoid arthritis. (2006) (61)
Predictors of cerebrovascular accidents in giant cell arteritis in a defined population. (2004) (61)
Asymptomatic hyperuricemia and serum uric acid concentration correlate with subclinical atherosclerosis in psoriatic arthritis patients without clinically evident cardiovascular disease. (2009) (61)
Genetics of vasculitis (2015) (60)
Interleukin 1beta gene polymorphism association with severe renal manifestations and renal sequelae in Henoch-Schönlein purpura. (2004) (60)
Anti-TNF-Alpha-Adalimumab Therapy Is Associated with Persistent Improvement of Endothelial Function without Progression of Carotid Intima-Media Wall Thickness in Patients with Rheumatoid Arthritis Refractory to Conventional Therapy (2012) (60)
Particle Repositioning Maneuver Versus Brandt-Daroff Exercise for Treatment of Unilateral Idiopathic BPPV of the Posterior Semicircular Canal: A Randomized Prospective Clinical Trial With Short- and Long-Term Outcome (2012) (60)
IL-6 promoter polymorphism at position -174 modulates the phenotypic expression of polymyalgia rheumatica in biopsy-proven giant cell arteritis. (2002) (59)
HLA-DRB1*01 association with Henoch-Schönlein purpura in patients from northwest Spain. (2001) (59)
Giant Cell Arteritis and Polymyalgia Rheumatica: an Update (2015) (59)
A Genome-wide Association Study Identifies Risk Alleles in Plasminogen and P4HA2 Associated with Giant Cell Arteritis. (2017) (58)
Association of FCGR2A and FCGR2A-FCGR3A haplotypes with susceptibility to giant cell arteritis (2006) (57)
Seronegative rheumatoid arthritis in elderly and polymyalgia rheumatica have similar patterns of HLA association. (2001) (57)
Study of functional variants of the BANK1 gene in rheumatoid arthritis. (2009) (56)
Relapses in patients with Henoch–Schönlein purpura (2016) (56)
Tocilizumab in uveitis refractory to other biologic drugs: a study of 3 cases and a literature review. (2014) (56)
Human leukocyte antigen-DRB1*1502 (DR2Dw12) transgene reduces incidence and severity of arthritis in mice. (1996) (55)
Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategy (2017) (55)
Predictors of positive 18F-FDG PET/CT-scan for large vessel vasculitis in patients with persistent polymyalgia rheumatica. (2019) (54)
A new immunometabolic perspective of intervertebral disc degeneration (2021) (54)
Identification of a new putative functional IL18 gene variant through an association study in systemic lupus erythematosus. (2009) (53)
Giant cell arteritis without clinically evident vascular involvement in a defined population. (2004) (53)
Polymyalgia manifestations in different conditions mimicking polymyalgia rheumatica. (2000) (53)
Steroid therapy improves endothelial function in patients with biopsy-proven giant cell arteritis. (2006) (52)
A combined large-scale meta-analysis identifies COG6 as a novel shared risk locus for rheumatoid arthritis and systemic lupus erythematosus (2016) (51)
New insight on the Xq28 association with systemic sclerosis (2013) (51)
Polymorphism at codon 469 of the intercellular adhesion molecule-1 locus is associated with protection against severe gastrointestinal complications in Henoch-Schönlein purpura. (2001) (51)
Tocilizumab in patients with Takayasu arteritis: a retrospective study and literature review. (2016) (50)
Association of a CD24 gene polymorphism with susceptibility to systemic lupus erythematosus. (2007) (49)
Anti‐tumor necrosis factor‐alpha therapy improves endothelial function and arterial stiffness in patients with moderate to severe psoriasis: A 6‐month prospective study (2016) (47)
Successful Optimization of Adalimumab Therapy in Refractory Uveitis Due to Behçet's Disease. (2018) (47)
Atherosclerosis in patients with biopsy-proven giant cell arteritis. (2007) (47)
Fever in biopsy-proven giant cell arteritis: clinical implications in a defined population. (2004) (46)
Short-term improvement following dry needle stimulation of tender points in fibromyalgia (2014) (46)
Identification of the PTPN22 functional variant R620W as susceptibility genetic factor for giant cell arteritis (2013) (46)
Interleukin 12 (IL12B) and interleukin 12 receptor (IL12RB1) gene polymorphisms in rheumatoid arthritis. (2005) (46)
Timing of onset affects arthritis presentation pattern in antisyntethase syndrome. (2018) (46)
TNF-alpha antagonist therapy improves insulin sensitivity in non-diabetic ankylosing spondylitis patients. (2012) (46)
Natural Molecules for Healthy Lifestyles: Oleocanthal from Extra Virgin Olive Oil. (2019) (45)
Definition and epidemiology (2016) (45)
Association between functional haplotypes of vascular endothelial growth factor and renal complications in Henoch-Schönlein purpura. (2006) (45)
Audiovestibular Manifestations in Patients With Limited Systemic Sclerosis and Centromere Protein-B (CENP-B) Antibodies (2008) (45)
Clinical follow-up predictors of disease pattern change in anti-Jo1 positive anti-synthetase syndrome: Results from a multicenter, international and retrospective study. (2017) (44)
Ischemic heart disease in patients from Northwest Spain with biopsy proven giant cell arteritis. A population based study. (2005) (44)
A genome-wide association study suggests the HLA Class II region as the major susceptibility locus for IgA vasculitis (2017) (43)
The effect of biologic therapy different from infliximab or adalimumab in patients with refractory uveitis due to Behçet's disease: results of a multicentre open-label study. (2016) (43)
Deletion of LCE3C and LCE3B is a susceptibility factor for psoriatic arthritis: a study in Spanish and Italian populations and meta-analysis. (2011) (43)
Anti-TNF-alpha therapy does not modulate leptin in patients with severe rheumatoid arthritis. (2009) (43)
Risk factors associated with renal lithiasis during uricosuric treatment of hyperuricemia in patients with Gout (2010) (43)
HLA-B35 association with nephritis in Henoch-Schönlein purpura. (2002) (43)
Prevalence of HLA-B27 and subtypes of HLA-B27 associated with ankylosing spondylitis in Galicia, Spain. (2004) (43)
The effect of JAK1/JAK2 inhibition in rheumatoid arthritis: efficacy and safety of baricitinib. (2019) (43)
SCORE and REGICOR function charts underestimate the cardiovascular risk in Spanish patients with rheumatoid arthritis (2013) (43)
Short-term efficacy of topical capsaicin therapy in severely affected fibromyalgia patients (2013) (42)
Study of Association of CD40-CD154 Gene Polymorphisms with Disease Susceptibility and Cardiovascular Risk in Spanish Rheumatoid Arthritis Patients (2012) (42)
CCR5Δ32 variant and cardiovascular disease in patients with rheumatoid arthritis: a cohort study (2011) (42)
Lack of echocardiographic and Doppler abnormalities in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors. (2006) (41)
Influence of the IL6 Gene in Susceptibility to Systemic Sclerosis (2012) (40)
An Audit of the Variability of Diagnosis and Management of Gout in the Rheumatology Setting: The Gout Evaluation and Management Study (2011) (40)
Cancer in biopsy-proven giant cell arteritis. A population-based study. (2007) (39)
Expression of osteoprotegerin and its ligands, RANKL and TRAIL, in rheumatoid arthritis (2016) (39)
Interleukin 12 (IL12B), interleukin 12 receptor (IL12RB1) and interleukin 23 (IL23A) gene polymorphism in systemic lupus erythematosus. (2005) (39)
IgA Vasculitis: Genetics and Clinical and Therapeutic Management (2018) (39)
Genetic Markers of Cardiovascular Disease in Rheumatoid Arthritis (2012) (39)
Single-organ cutaneous small-vessel vasculitis according to the 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides: a study of 60 patients from a series of 766 cutaneous vasculitis cases. (2015) (38)
Increased prevalence of subclinical atherosclerosis in patients with hidradenitis suppurativa (HS). (2016) (38)
A multicenter study confirms CD226 gene association with systemic sclerosis-related pulmonary fibrosis (2012) (38)
Influence of the IL17A locus in giant cell arteritis susceptibility (2014) (37)
Endothelial dysfunction in rheumatoid arthritis: influence of HLA-DRB1 alleles. (2004) (37)
Influence of nitric oxide synthase gene polymorphisms on the risk of cardiovascular events in rheumatoid arthritis. (2009) (37)
Assessment of cardiovascular risk in rheumatoid arthritis: impact of the new EULAR recommendations on the score cardiovascular risk index (2011) (37)
HDL cholesterol efflux capacity in rheumatoid arthritis patients: contributing factors and relationship with subclinical atherosclerosis (2017) (37)
HLA and non-HLA genes in Behçet’s disease: a multicentric study in the Spanish population (2013) (37)
Implications of upper respiratory tract infections and drugs in the clinical spectrum of Henoch-Schönlein purpura in children. (2004) (37)
Independent Relationship of Osteoprotegerin Concentrations with Endothelial Activation and Carotid Atherosclerosis in Patients with Severe Rheumatoid Arthritis (2014) (36)
Clinical approach to cutaneous vasculitis (2005) (36)
Nailfold Capillaroscopy Characteristics of Antisynthetase Syndrome and Possible Clinical Associations: Results of a Multicenter International Study (2018) (36)
Clinical association between Kikuchi׳s disease and systemic lupus erythematosus: A systematic literature review. (2017) (36)
Adipokines, Biomarkers of Endothelial Activation, and Metabolic Syndrome in Patients with Ankylosing Spondylitis (2014) (36)
Efficacy of Anti-IL6-Receptor Tocilizumab in Refractory Cystoid Macular Edema of Birdshot Retinochoroidopathy Report of Two Cases and Literature Review (2017) (36)
The novel adipokine progranulin counteracts IL-1 and TLR4-driven inflammatory response in human and murine chondrocytes via TNFR1 (2016) (36)
Audiovestibular Manifestations in Patients With Ankylosing Spondylitis (2011) (36)
Rapid beneficial effect of the IL-6 receptor blockade on insulin resistance and insulin sensitivity in non-diabetic patients with rheumatoid arthritis. (2019) (36)
Deletion of the late cornified envelope genes, LCE3C and LCE3B, is associated with rheumatoid arthritis. (2010) (36)
Inducible nitric oxide synthase polymorphism is associated with susceptibility to Henoch-Schönlein purpura in northwestern Spain. (2005) (35)
Implication of IL-2/IL-21 region in systemic sclerosis genetic susceptibility (2012) (35)
Association of CD24 gene polymorphisms with susceptibility to biopsy-proven giant cell arteritis. (2008) (35)
Carotid ultrasound in the cardiovascular risk stratification of patients with rheumatoid arthritis: when and for whom? (2012) (35)
COVID‐19 patients with psoriasis and psoriatic arthritis on biologic immunosuppressant therapy vs apremilast in North Spain (2020) (35)
The interleukin 23 receptor gene does not confer risk to systemic sclerosis and is not associated with systemic sclerosis disease phenotype (2008) (35)
Anti-citrullinated peptide antibodies and their value for predicting responses to biologic agents: a review (2016) (35)
Benign Paroxysmal Positional Vertigo and Clinical Test of Sensory Interaction and Balance in Systemic Sclerosis (2008) (34)
Association Between Toll-like Receptor 4 Gene Polymorphism and Biopsy-proven Giant Cell Arteritis (2009) (34)
Endothelial nitric oxide synthase haplotype associations in biopsy-proven giant cell arteritis. (2003) (34)
Ear, Nose and Throat Manifestations of Wegener's Granulomatosis (Granulomatosis With Polyangiitis) (2012) (34)
Carotid artery plaque in women with rheumatoid arthritis and low estimated cardiovascular disease risk: a cross-sectional study (2015) (34)
Vitamin D deficiency in chronic inflammatory rheumatic diseases: results of the cardiovascular in rheumatology [CARMA] study (2015) (34)
Lipoprotein(a) concentrations in rheumatoid arthritis on biologic therapy: Results from the CARdiovascular in rheuMAtology study project. (2017) (33)
Influence of the STAT3 genetic variants in the susceptibility to psoriatic arthritis and Behcet's disease. (2013) (33)
Clinical spectrum time course of interstitial pneumonia with autoimmune features in patients positive for antisynthetase antibodies. (2017) (33)
Urticarial Vasculitis in Northern Spain (2014) (33)
Association between HLA-DRB1*15 and secondary Sjögren's syndrome in patients with rheumatoid arthritis. (2000) (33)
Lack of association between ankylosing spondylitis and a functional polymorphism of PTPN22 proposed as a general susceptibility marker for autoimmunity (2005) (32)
IL-6: linking chronic inflammation and vascular calcification (2019) (32)
Systemic and cerebral endothelial dysfunction in chronic migraine. A case-control study with an active comparator (2016) (32)
Association of HLA-B*41:02 with Henoch-Schönlein Purpura (IgA Vasculitis) in Spanish individuals irrespective of the HLA-DRB1 status (2015) (32)
The ZC3HC1 rs11556924 polymorphism is associated with increased carotid intima-media thickness in patients with rheumatoid arthritis (2013) (32)
Sex differences in patients with systemic lupus erythematosus from Northwest Spain (2013) (31)
Marked Independent Relationship between Circulating Interleukin-6 Concentrations and Endothelial Activation in Rheumatoid Arthritis (2013) (31)
High triglycerides and low high-density lipoprotein cholesterol lipid profile in rheumatoid arthritis: A potential link among inflammation, oxidative status, and dysfunctional high-density lipoprotein. (2017) (31)
Insulin resistance in systemic lupus erythematosus patients: contributing factors and relationship with subclinical atherosclerosis. (2017) (31)
Investigation of TLR5 and TLR7 as candidate genes for susceptibility to systemic lupus erythematosus. (2009) (31)
HLA-DRB1 association with Henoch-Schonlein purpura. (2014) (31)
Influence of interleukin 10 promoter polymorphisms in susceptibility to giant cell arteritis in Northwestern Spain. (2007) (31)
Drug-associated Cutaneous Vasculitis: Study of 239 Patients from a Single Referral Center (2014) (31)
Epistatic Interaction of ERAP1 and HLA-B in Behçet Disease: A Replication Study in the Spanish Population (2014) (31)
Decreased expression of methylene tetrahydrofolate reductase (MTHFR) gene in patients with rheumatoid arthritis. (2016) (30)
Atherosclerotic disease in axial spondyloarthritis: increased frequency of carotid plaques. (2015) (30)
Austrian syndrome: report of two new cases and literature review. (2006) (30)
Cardiovascular disease in rheumatoid arthritis. (2006) (30)
Sensitivity and Specificity of the CASPAR Criteria for Psoriatic Arthritis in a Family Medicine Clinic Setting (2008) (29)
CARD8 rs2043211 (p.C10X) polymorphism is not associated with disease susceptibility or cardiovascular events in Spanish rheumatoid arthritis patients. (2013) (29)
Osteoprotegerin Concentrations Relate Independently to Established Cardiovascular Disease in Rheumatoid Arthritis (2015) (29)
Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring in clinical practice: the spanish cohort of the COMORA study. (2017) (29)
Association of a functional inducible nitric oxide synthase promoter variant with susceptibility to biopsy-proven giant cell arteritis. (2005) (29)
Adipokines induce pro‐inflammatory factors in activated Cd4+ T cells from osteoarthritis patient (2017) (28)
Persistent chronic inflammation contributes to the development of cancer in patients with rheumatoid arthritis from a defined population of northwestern Spain. (2007) (28)
Efficacy and safety of abatacept in interstitial lung disease of rheumatoid arthritis: A systematic literature review. (2021) (28)
Cross‐disease Meta‐analysis of Genome‐wide Association Studies for Systemic Sclerosis and Rheumatoid Arthritis Reveals IRF4 as a New Common Susceptibility Locus (2016) (28)
Tocilizumab for the treatment of adult-onset Still’s disease (2019) (28)
Impaired HDL cholesterol efflux capacity in systemic lupus erythematosus patients is related to subclinical carotid atherosclerosis. (2020) (28)
SLC22A4, RUNX1, and SUMO4 polymorphisms are not associated with rheumatoid arthritis: a case-control study in a Spanish population. (2006) (27)
Paraoxonase 1 Activity Is Modulated by the rs662 Polymorphism and IgG Anti–High‐Density Lipoprotein Antibodies in Patients With Rheumatoid Arthritis: Potential Implications for Cardiovascular Disease (2016) (27)
Bone mass and vitamin D in patients with systemic sclerosis from two Spanish regions. (2012) (27)
Brief Report: IRF4 Newly Identified as a Common Susceptibility Locus for Systemic Sclerosis and Rheumatoid Arthritis in a Cross‐Disease Meta‐Analysis of Genome‐Wide Association Studies (2016) (27)
Early large vessel systemic vasculitis in adults. (2019) (27)
Evidence of New Risk Genetic Factor to Systemic Lupus Erythematosus: The UBASH3A Gene (2013) (26)
Golimumab in refractory uveitis associated to juvenile idiopathic arthritis: multicentre study of 7 cases and literature review. (2018) (26)
Identification of novel genetic markers associated with the clinical phenotypes of systemic sclerosis through a genome wide association strategy (2010) (26)
Infective endocarditis due to Streptococcus bovis in a series of nonaddict patients: clinical and morphological characteristics of 20 cases and review of the literature. (2003) (26)
Lack of Association between ABO, PPAP2B, ADAMST7, PIK3CG, and EDNRA and Carotid Intima-Media Thickness, Carotid Plaques, and Cardiovascular Disease in Patients with Rheumatoid Arthritis (2014) (26)
Association between IL-18 gene polymorphisms and biopsy-proven giant cell arteritis (2010) (26)
Lack of association between intercellular adhesion molecule-1 gene polymorphisms and giant cell arteritis. (2001) (25)
Antisynthetase syndrome or what else? Different perspectives indicate the need for new classification criteria (2017) (25)
Lack of association of a functional single nucleotide polymorphism of PTPN22, encoding lymphoid protein phosphatase, with susceptibility to biopsy-proven giant cell arteritis. (2005) (25)
Analysis of vascular endothelial growth factor (VEGF) functional variants in rheumatoid arthritis. (2005) (25)
Epistatic Interaction between BANK1 and BLK in Rheumatoid Arthritis: Results from a Large Trans-Ethnic Meta-Analysis (2013) (25)
Influence of MHCIITA rs3087456 and rs4774 polymorphisms in the susceptibility to cardiovascular disease of patients with rheumatoid arthritis. (2012) (25)
Lack of association of PTPN22, STAT4 and TRAF1/C5 gene polymorphisms with cardiovascular risk in rheumatoid arthritis. (2010) (25)
Localized vasculitis of the gastrointestinal tract: a case report and literature review. (2008) (24)
Lack of association between ADIPOQ rs266729 and ADIPOQ rs1501299 polymorphisms and cardiovascular disease in rheumatoid arthritis patients. (2011) (24)
Protective Role of the Interleukin 33 rs3939286 Gene Polymorphism in the Development of Subclinical Atherosclerosis in Rheumatoid Arthritis Patients (2015) (24)
Lack of association between macrophage migration inhibitory factor-173 gene polymorphism with disease susceptibility and cardiovascular risk in rheumatoid arthritis patients from northwestern Spain. (2010) (24)
Impaired beta cell function is present in nondiabetic rheumatoid arthritis patients (2013) (24)
Corticotropin releasing hormone promoter polymorphisms in giant cell arteritis and polymyalgia rheumatica. (2002) (24)
Giant cell arteritis: is the clinical spectrum of the disease changing? (2019) (24)
Cross-phenotype analysis of Immunochip data identifies KDM4C as a relevant locus for the development of systemic vasculitis (2018) (24)
Anakinra for the treatment of adult-onset Still’s disease (2018) (23)
Impact of Comorbidity on Physical Function in Patients With Ankylosing Spondylitis and Psoriatic Arthritis Attending Rheumatology Clinics: Results From a Cross‐Sectional Study (2020) (23)
Cardiovascular risk stratification in axial spondyloarthritis: carotid ultrasound is more sensitive than coronary artery calcification score to detect high-cardiovascular risk axial spondyloarthritis patients. (2018) (23)
Efficacy of a multidisciplinary treatment program in patients with severe fibromyalgia (2012) (23)
Association of a non-synonymous functional variant of the ITGAM gene with systemic sclerosis (2011) (23)
Adiponectin and resistin serum levels in non-diabetic ankylosing spondylitis patients undergoing TNF-α antagonist therapy. (2013) (23)
Carotid ultrasound in the cardiovascular risk stratification of patients with ankylosing spondylitis: results of a population-based study. (2016) (23)
Vascular endothelial growth factor A and cardiovascular disease in rheumatoid arthritis patients. (2011) (23)
Evidence of association of the NLRP1 gene with giant cell arteritis (2012) (23)
Golimumab in uveitis previously treated with other anti-TNF-alpha drugs: a retrospective study of three cases from a single centre and literature review. (2014) (23)
Serum Levels of Anti-PON1 and Anti-HDL Antibodies as Potential Biomarkers of Premature Atherosclerosis in Systemic Lupus Erythematosus (2017) (23)
Carotid plaques as predictors of cardiovascular events in patients with Rheumatoid Arthritis. Results from a 5-year-prospective follow-up study. (2020) (22)
Biologic therapy in severe and refractory peripheral ulcerative keratitis (PUK). Multicenter study of 34 patients. (2020) (22)
Short-term effect of anti-TNF-alpha therapy on nitric oxide production in patients with severe rheumatoid arthritis. (2009) (22)
Successful effect of tocilizumab in anti-TNF-α-induced palmoplantar pustulosis in rheumatoid arthritis. (2012) (22)
Evidence for PTPN22 R620W Polymorphism As the Sole Common Risk Variant for Rheumatoid Arthritis in the 1p13.2 Region (2011) (22)
Inflammation, endothelial function and atherosclerosis in rheumatoid arthritis (2012) (22)
Association of acid phosphatase locus 1*C allele with the risk of cardiovascular events in rheumatoid arthritis patients (2011) (22)
Study of six X-linked tetranucleotide microsatellites: population data from five Spanish regions (2006) (22)
Rheumatoid arthritis: Obesity impairs efficacy of anti-TNF therapy in patients with RA (2012) (22)
Lack of association between LEP rs2167270 (19 G>A) polymorphism and disease susceptibility and cardiovascular disease in patients with rheumatoid arthritis. (2011) (21)
Leptin and visfatin serum levels in non-diabetic ankylosing spondylitis patients undergoing TNF-α antagonist therapy. (2013) (21)
Osteoprotegerin correlates with disease activity and endothelial activation in non-diabetic ankylosing spondylitis patients undergoing TNF-α antagonist therapy. (2014) (21)
Interferon regulatory factor 5 genetic variants are associated with cardiovascular disease in patients with rheumatoid arthritis (2014) (21)
Cholesteryl Ester Transfer Protein in Patients with Rheumatoid Arthritis (2013) (21)
No primary association of MICA polymorphism with systemic lupus erythematosus. (2006) (21)
Lack of association between IL6 single nucleotide polymorphisms and cardiovascular disease in Spanish patients with rheumatoid arthritis. (2011) (21)
Tocilizumab: from the rheumatology practice to the fight against COVID-19, a virus infection with multiple faces (2020) (21)
Lack of association between TLR4 rs4986790 polymorphism and risk of cardiovascular disease in patients with rheumatoid arthritis. (2012) (20)
Human leukocyte antigen-DQB1 and -DRB1 associations in patients with idiopathic sudden sensorineural hearing loss from a defined population of Northwest Spain (2005) (20)
Smoking cessation is associated with lower disease activity and predicts cardiovascular risk reduction in rheumatoid arthritis patients (2019) (20)
Identification of the oxidative stress-related gene MSRA as a rheumatoid arthritis susceptibility locus by genome-wide pathway analysis. (2010) (20)
The Framingham Score and the Systematic Coronary Risk Evaluation at Low Cutoff Values Are Useful Surrogate Markers of High-risk Subclinical Atherosclerosis in Patients with Rheumatoid Arthritis (2016) (20)
Anti-TNF-α therapy reduces endothelial cell activation in non-diabetic ankylosing spondylitis patients (2015) (20)
Investigations into Audiovestibular Manifestations in Patients with Psoriatic Arthritis (2014) (19)
GIMAP and Behçet disease: no association in the European population (2014) (19)
Analysis of the REL polymorphism rs13031237 in autoimmune diseases (2010) (19)
The Spectrum of Interstitial Lung Disease Associated with Autoimmune Diseases: Data of a 3.6-Year Prospective Study from a Referral Center of Interstitial Lung Disease and Lung Transplantation † (2020) (19)
Use of positron emission tomography (PET) for the diagnosis of large-vessel vasculitis. (2015) (19)
Influence of CD40 rs1883832 Polymorphism in Susceptibility to and Clinical Manifestations of Biopsy-proven Giant Cell Arteritis (2010) (19)
Inflammatory Arthritis and Heart Disease. (2018) (19)
Current and emerging diagnosis tools and therapeutics for giant cell arteritis (2018) (19)
The Spanish version of the 2010 American College of Rheumatology Preliminary Diagnostic Criteria for fibromyalgia: reliability and validity assessment. (2016) (18)
Influence of elevated-CRP level-related polymorphisms in non-rheumatic Caucasians on the risk of subclinical atherosclerosis and cardiovascular disease in rheumatoid arthritis (2016) (18)
Tocilizumab for the treatment of rheumatoid arthritis (2012) (18)
Brief Report: Association of HLA–DRB1*01 With IgA Vasculitis (Henoch‐Schönlein) (2015) (18)
Role of rs1343151 IL23R and rs3790567 IL12RB2 Polymorphisms in Biopsy-proven Giant Cell Arteritis (2011) (18)
Lack of association between endothelial nitric oxide synthase polymorphisms and Henoch-Schönlein purpura. (2004) (18)
Implication of the age in the clinical spectrum of giant cell arteritis. (2008) (18)
Proprotein convertase subtilisin/kexin type 9 in rheumatoid arthritis. (2016) (18)
A Candidate Gene Approach Identifies an IL33 Genetic Variant as a Novel Genetic Risk Factor for GCA (2014) (18)
Evidence for uncoupling of clinical and 18-FDG activity of PET/CT scan improvement in tocilizumab-treated patients with large-vessel giant cell arteritis. (2020) (17)
CD4+CD25+ T Cell-Dependent Inhibition of Autoimmunity in Transgenic Mice Overexpressing Human Bcl-2 in T Lymphocytes1 (2007) (17)
Standardization procedure for flow cytometry data harmonization in prospective multicenter studies (2020) (17)
Tocilizumab in giant cell arteritis: differences between the GiACTA trial and a multicentre series of patients from the clinical practice. (2020) (17)
Study of a functional polymorphism in thep53 gene in systemic lupus erythematosus: lack of replication in a Spanish population (2006) (16)
Lack of association between hypoxia inducible factor-1 alpha gene polymorphisms and biopsy-proven giant cell arteritis. (2010) (16)
Polymorphism of the MHC class II Eb gene determines the protection against collagen-induced arthritis (1995) (16)
Antibodies to paraoxonase 1 are associated with oxidant status and endothelial activation in rheumatoid arthritis. (2016) (16)
Henoch-Schönlein purpura (IgA vasculitis): the paradox of the different incidence and clinical spectrum in children and adults. (2017) (16)
Controversies on the use of corticosteroid therapy in children with Henoch-Schönlein purpura. (2005) (16)
Brief Report: Lack of Replication of an Association Between Anti–Citrullinated Fibrinogen and Subclinical Atherosclerosis in Patients With Rheumatoid Arthritis (2015) (16)
Identification of a 3′‐Untranslated Genetic Variant of RARB Associated With Carotid Intima‐Media Thickness in Rheumatoid Arthritis: A Genome‐Wide Association Study (2019) (16)
Oral Calcidiol Is More Effective Than Cholecalciferol Supplementation to Reach Adequate 25(OH)D Levels in Patients with Autoimmune Diseases Chronically Treated with Low Doses of Glucocorticoids: A “Real-Life” Study (2015) (16)
Role of the rs6822844 gene polymorphism at the IL2-IL21 region in biopsy-proven giant cell arteritis. (2011) (16)
New insights into the pathogenesis of giant cell arteritis and hopes for the clinic (2016) (16)
Relationship of abdominal adiposity and body composition with endothelial dysfunction in patients with rheumatoid arthritis. (2015) (16)
Lack of association of IL6R rs2228145 and IL6ST/gp130 rs2228044 gene polymorphisms with cardiovascular disease in patients with rheumatoid arthritis. (2011) (16)
Cutaneous vasculitis: a diagnostic approach. (2003) (16)
Association of CD247 Polymorphisms with Rheumatoid Arthritis: A Replication Study and a Meta-Analysis (2013) (16)
Rheumatoid arthritis: genetic variants as biomarkers of cardiovascular disease. (2014) (15)
Lack of association of NAMPT rs9770242 and rs59744560 polymorphisms with disease susceptibility and cardiovascular risk in patients with rheumatoid arthritis. (2011) (15)
TNF +489 polymorphism does not contribute to susceptibility to rheumatoid arthritis. (2002) (15)
Asymmetric dimethylarginine serum levels in non-diabetic ankylosing spondylitis patients undergoing TNF-α antagonist therapy. (2013) (15)
Kidney Function, Endothelial Activation and Atherosclerosis in Black and White Africans with Rheumatoid Arthritis (2015) (15)
Giant cell arteritis: more than a cranial disease. (2020) (15)
Lack of association of a functional -94ins/delATTG NFKB1 promoter polymorphism with susceptibility and clinical expression of biopsy-proven giant cell arteritis in northwest Spain. (2006) (15)
Analysis of Ancestral and Functionally Relevant CD5 Variants in Systemic Lupus Erythematosus Patients (2014) (15)
Study of the role of functional variants of SLC22A4, RUNX1 and SUMO4 in systemic lupus erythematosus (2005) (15)
Cardiovascular risk assessment according to a national calibrated score risk index in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors. (2014) (15)
An Update on the Role of Leptin in the Immuno-Metabolism of Cartilage (2021) (15)
Giant left atrial myxoma mimicking severe mitral valve stenosis. (2008) (15)
Refractory polymyalgia rheumatica as presenting manifestation of large-vessel vasculitis associated to sarcoidosis. Successful response to adalimumab. (2012) (14)
Cutaneous Vasculitis: A Rheumatologist Perspective (2013) (14)
Confirmation of CCR6 as a risk factor for anti-topoisomerase I antibodies in systemic sclerosis. (2015) (14)
A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease (2020) (14)
NPSR1 Gene Is Associated with Reduced Risk of Rheumatoid Arthritis (2012) (14)
Medical management of polymyalgia rheumatica (2010) (14)
Interleukin 1 beta (IL1ß) rs16944 genetic variant as a genetic marker of severe renal manifestations and renal sequelae in Henoch-Schönlein purpura. (2016) (14)
Replication of association of the interleukin 23 receptor rs1343151 variant with rheumatoid arthritis in Caucasian sample sets (2011) (14)
Henoch-Schönlein purpura and cutaneous leukocytoclastic angiitis exhibit different HLA-DRB1 associations. (2002) (14)
The increased risk of ventricular diastolic dysfunction and congestive heart failure in patients with rheumatoid arthritis is independent of the duration of the disease. (2005) (14)
[Audiovestibular manifestations in systemic vasculitis]. (2009) (14)
Corticoids synergize with IL-1 in the induction of LCN2. (2017) (14)
Lack of association between macrophage migration inhibitory factor gene (-173 G/C) polymorphism and cutaneous vasculitis. (2006) (14)
Atherosclerosis in Rheumatoid Arthritis (2012) (14)
Influence of coronary artery disease and subclinical atherosclerosis related polymorphisms on the risk of atherosclerosis in rheumatoid arthritis (2017) (13)
Relationship between endothelial dysfunction and osteoprotegerin, vitamin D, and bone mineral density in patients with rheumatoid arthritis. (2015) (13)
Lack of Association Between TRAF1/C5 Gene Polymorphisms and Biopsy-proven Giant Cell Arteritis (2010) (13)
SMAD3 rs17228212 Gene Polymorphism Is Associated with Reduced Risk to Cerebrovascular Accidents and Subclinical Atherosclerosis in Anti-CCP Negative Spanish Rheumatoid Arthritis Patients (2013) (13)
Two Polymorphisms in the Epithelial Cell-Derived Neutrophil-Activating Peptide (ENA-78) Gene (2005) (13)
Genetic risk scores and number of autoantibodies in patients with rheumatoid arthritis (2013) (13)
Biologic therapy in ANCA-negative vasculitis. (2015) (13)
New Criteria Needed for Antisynthetase Syndrome. (2017) (13)
Polymyalgia rheumatica as presenting manifestation of vasculitis involving the lower extremities in a patient with ulcerative colitis. (2012) (13)
Association study of MIA3 rs17465637 polymorphism with cardiovascular disease in rheumatoid arthritis patients. (2012) (13)
Psoriasis: a skin disease associated with increased cardiovascular risk. (2012) (13)
Association of circulating calprotectin with lipid profile in axial spondyloarthritis (2018) (13)
Multiple parosteal lipoma associated to polyarthritis. (2006) (13)
Association of Trabecular Bone Score with Inflammation and Adiposity in Patients with Psoriasis: Effect of Adalimumab Therapy (2016) (13)
Levels of the Novel Endogenous Antagonist of Ghrelin Receptor, Liver-Enriched Antimicrobial Peptide-2, in Patients with Rheumatoid Arthritis (2020) (13)
Functional capacity in rheumatoid arthritis patients: comparison between Spanish and Brazilian sample (2011) (13)
Analysis of the Interferon Gamma (rs2430561, +874T/A) Functional Gene Variant in Relation to the Presence of Cardiovascular Events in Rheumatoid Arthritis (2012) (13)
Antitumour necrosis factor α treatment reduces retinol-binding protein 4 serum levels in non-diabetic ankylosing spondylitis patients (2013) (13)
MCP-1 gene haplotype association in biopsy proven giant cell arteritis. (2005) (13)
Lack of association between IL-1 cluster and TNF-alpha gene polymorphisms and giant cell arteritis. (2002) (12)
Sex and Cardiovascular Involvement in Inflammatory Joint Diseases (2019) (12)
Treatment of giant cell arteritis. (2019) (12)
Incretins in patients with rheumatoid arthritis (2017) (12)
Cardiovascular mortality and cardiovascular event rates in patients with inflammatory rheumatic diseases in the CARdiovascular in rheuMAtology (CARMA) prospective study-results at 5 years of follow-up. (2020) (12)
Protein tyrosine phosphatase non-receptor 22 and C-Src tyrosine kinase genes are down-regulated in patients with rheumatoid arthritis (2017) (12)
Molecular screening and association study of IL15 gene polymorphisms in rheumatoid arthritis. (2007) (12)
Role of the CCR5/Δ32CCR5 polymorphism in biopsy-proven giant cell arteritis. (2011) (12)
Disease Damage Influences Cardiovascular Risk Reclassification Based on Carotid Ultrasound in Patients with Systemic Lupus Erythematosus (2019) (12)
The lp13.3 genomic region -rs599839- is associated with endothelial dysfunction in patients with rheumatoid arthritis (2012) (12)
Functional Variants of Fc Gamma Receptor (FCGR2A) and FCGR3A Are Not Associated with Susceptibility to Systemic Sclerosis in a Large European Study (EUSTAR) (2010) (12)
Retinol-binding Protein 4 in Rheumatoid Arthritis-related Insulin Resistance and β-cell Function (2014) (12)
Significant sE-Selectin levels reduction after 6 months of anti-TNF-α therapy in non-diabetic patients with moderate-to-severe psoriasis (2017) (12)
Disease Activity Influences Cardiovascular Risk Reclassification Based on Carotid Ultrasound in Patients with Psoriatic Arthritis (2019) (12)
BioLogic THERAPY IN COVID-19 (2020) (12)
Giant cell arteritis in Mediterranean countries: comment on the article by Salvarani et al. (1992) (12)
Asymmetric dimethylarginine but not osteoprotegerin correlates with disease severity in patients with moderate‐to‐severe psoriasis undergoing anti‐tumor necrosis factor‐α therapy (2016) (12)
IL-18 gene polymorphisms in Henoch-Schönlein purpura. (2010) (12)
Omentin: a biomarker of cardiovascular risk in individuals with axial spondyloarthritis (2020) (12)
Association of a rare variant of the TNFSF13B gene with susceptibility to Rheumatoid Arthritis and Systemic Lupus Erythematosus (2018) (12)
Reclassification into very-high cardiovascular risk after carotid ultrasound in patients with axial spondyloarthritis. (2020) (12)
Rituximab in the Treatment of Interstitial Lung Disease Associated with Autoimmune Diseases: Experience from a Single Referral Center and Literature Review (2020) (11)
Subclinical atherosclerosis in patients with psoriatic arthritis. (2008) (11)
C-Reactive Protein Gene Polymorphisms in Biopsy-proven Giant Cell Arteritis from Northwestern Spain (2008) (11)
Novel association of acid phosphatase locus 1*C allele with systemic lupus erythematosus. (2012) (11)
Lack of association between interleukin-6 promoter polymorphism at position -174 and Henoch-Schönlein purpura (2007) (11)
Apelin serum levels in non-diabetic ankylosing spondylitis patients undergoing TNF-α antagonist therapy. (2013) (11)
Diabetes mellitus and cardiovascular risk management in patients with rheumatoid arthritis: an international audit (2021) (11)
Antitumour necrosis factor-α therapy modulates angiopoietin-2 serum levels in non-diabetic ankylosing spondylitis patients (2013) (11)
Long-term Follow-up and Optimization of Infliximab in Refractory Uveitis Due to Behçet Disease: National Study of 103 White Patients (2020) (11)
Circulating levels of adiponectin, leptin, resistin and visfatin in non-diabetics patients with hidradenitis suppurativa (2019) (11)
E-selectin polymorphism in erythema nodosum secondary to sarcoidosis. (2004) (11)
Generalized granuloma annulare and giant cell arteritis. (2008) (11)
Endothelial Progenitor Cells as a Potential Biomarker in Interstitial Lung Disease Associated with Rheumatoid Arthritis (2020) (11)
Subclinical atherosclerotic disease in ankylosing spondylitis and non-radiographic axial spondyloarthritis. A multicenter study on 806 patients. (2021) (11)
Vitamin D receptor GATG haplotype association with atherosclerotic disease in patients with rheumatoid arthritis. (2016) (11)
Lack of association between toll-like receptor 4 gene polymorphism and Henoch-Schönlein purpura. (2010) (11)
Glucocorticoid-related cardiovascular and cerebrovascular events in rheumatic diseases: myth or reality? (2007) (11)
Role of PTPN22 and CSK gene polymorphisms as predictors of susceptibility and clinical heterogeneity in patients with Henoch-Schönlein purpura (IgA vasculitis) (2015) (11)
Unmet needs in the management of cardiovascular risk in inflammatory joint diseases (2019) (11)
Isolated pulmonary vasculitis: case report and literature review. (2015) (11)
The 11q23.3 genomic region-rs964184-is associated with cardiovascular disease in patients with rheumatoid arthritis. (2013) (11)
Pacemaker infection due to Aspergillus: report of two cases and literature review (2005) (11)
Lack of association between macrophage migration inhibitory factor gene polymorphism and giant cell arteritis. (2005) (11)
Analysis of the association between CD40 and CD40 ligand polymorphisms and systemic sclerosis (2012) (11)
Role of the C8orf13-BLK region in biopsy-proven giant cell arteritis. (2010) (11)
Investigation of a PON1 gene polymorphism (rs662 polymorphism) as predictor of subclinical atherosclerosis in patients with rheumatoid arthritis (2014) (11)
Lack of association between altitude and incidence of giant cell arteritis in Northwest Spain. (2004) (11)
Inflammation: NSAIDs and cardiovascular risk in arthritis (2017) (10)
Disease activity influences the reclassification of rheumatoid arthritis into very high cardiovascular risk (2021) (10)
Combined use of QRISK3 and SCORE as predictors of carotid plaques in patients with rheumatoid arthritis. (2020) (10)
KCNA5 gene is not confirmed as a systemic sclerosis-related pulmonary arterial hypertension genetic susceptibility factor (2012) (10)
Osteoprotegerin CGA Haplotype Protection against Cerebrovascular Complications in Anti-CCP Negative Patients with Rheumatoid Arthritis (2014) (10)
Benign Paroxysmal Positional Vertigo and Clinical Test of Sensory Interaction and Balance in Ankylosing Spondylitis (2011) (10)
Rheumatoid arthritis and accelerated atherogenesis. (2004) (10)
CXCL5 Gene Polymorphism Association with Diabetes Mellitus (2012) (10)
Leptin in Osteoarthritis and Rheumatoid Arthritis: Player or Bystander? (2022) (10)
Differences in Capacity of High‐Density Lipoprotein Cholesterol Efflux Between Patients With Systemic Lupus Erythematosus and Rheumatoid Arthritis (2020) (10)
Influence of MUC5B gene on antisynthetase syndrome (2020) (10)
Identification of streptococcal proteins reacting with sera from Behçet's disease and rheumatic disorders (2010) (9)
Proprotein convertase subtilisin/kexin type 9 is related to disease activity and damage in patients with systemic erythematosus lupus (2020) (9)
Serum cathepsin S and cystatin C: relationship to subclinical carotid atherosclerosis in rheumatoid arthritis. (2016) (9)
Interleukin-6 receptor blockade or TNFα inhibition for reducing glycaemia in patients with RA and diabetes: post hoc analyses of three randomised, controlled trials (2020) (9)
Optic neuritis following treatment with isoniazid in a hemodialyzed patient. (1993) (9)
Carotid intima-media thickness and endothelial function: useful surrogate markers for establishing cardiovascular risk in patients with inflammatory rheumatic disease (2008) (9)
Patients with Ankylosing Spondylitis and Low Disease Activity because of Anti-TNF-Alpha Therapy Have Higher TRAIL Levels Than Controls: A Potential Compensatory Effect (2014) (9)
Cardiovascular risk factor assessment: still an unmet need in chronic inflammatory diseases (2016) (9)
Audiovestibular manifestations in systemic vasculitis (2009) (9)
Lack of association between A561C E-selectin polymorphism and large and small-sized blood vessel vasculitides. (2002) (9)
TNF-related apoptosis-inducing ligand and cardiovascular disease in rheumatoid arthritis. (2015) (9)
A rare polymorphism in Toll Like Receptor 2 is associated with systemic sclerosis phenotype and increases production of inflammatory mediators (2011) (9)
Relationship Between Insulin Sensitivity and β-Cell Secretion in Nondiabetic Subjects with Rheumatoid Arthritis (2018) (9)
Applicability of the 2006 European League Against Rheumatism (EULAR) criteria for the classification of Henoch-Schönlein purpura. An analysis based on 766 patients with cutaneous vasculitis. (2015) (9)
Correlation between insulin resistance and serum ghrelin in non-diabetic ankylosing spondylitis patients undergoing anti-TNF-α therapy. (2013) (9)
Gene polymorphisms and therapy in rheumatoid arthritis (2016) (9)
Otorhinolaryngological manifestations in patients with Behçet disease (2014) (9)
Hyperlipoprotein(a) in patients with spondyloarthritis: results of the Cardiovascular in Rheumatology (CARMA) project. (2019) (8)
Drug therapies for polymyalgia rheumatica: a pharmacotherapeutic update (2018) (8)
Interleukin 12 ( IL 12 B ) , interleukin 12 receptor ( IL 12 RB 1 ) and interleukin 23 ( IL 23 A ) gene polymorphism in systemic lupus erythematosus (2005) (8)
The role of biologics in the treatment of giant cell arteritis (2018) (8)
Oculographic, Clinical Test of Sensory Integration and Balance and Computerized Dynamic Posturography Findings in Patients With Psoriatic Arthritis. (2017) (8)
Points to consider in cardiovascular disease risk management among patients with rheumatoid arthritis living in South Africa, an unequal middle income country (2020) (8)
Incidence of first cardiovascular event in Spanish patients with inflammatory rheumatic diseases: prospective data from the CARMA project. (2019) (8)
Anti-IL-6 therapy reduces leptin serum levels in patients with rheumatoid arthritis. (2020) (8)
ABATACEPT IN MONOTHERAPY VERSUS COMBINED IN INTERSTITIAL LUNG DISEASE OF RHEUMATOID ARTHRITIS. MULTICENTER STUDY OF 263 CAUCASIAN PATIENTS. (2021) (8)
Prediction of cardiovascular events in rheumatoid arthritis using risk age calculations: evaluation of concordance across risk age models (2020) (8)
Apremilast in refractory orogenital ulcers and other manifestations of Behçet's disease. A national multicentre study of 51 cases in clinical practice. (2020) (8)
Role of the rs 6822844 gene polymorphism at the IL 2-IL 21 region in biopsy-proven giant cell arteritis (2006) (8)
Tocilizumab in refractory giant cell arteritis. Monotherapy versus combined therapy with conventional immunosuppressive drugs. Observational multicenter study of 134 patients. (2021) (8)
Treatment of polymyalgia rheumatica. (2019) (8)
Cranial and extracranial giant cell arteritis share similar HLA-DRB1 association. (2020) (8)
Pollutants make rheumatic diseases worse: Facts on polychlorinated biphenyls (PCBs) exposure and rheumatic diseases. (2016) (8)
Use of statins is associated with a lower prevalence of generalised osteoarthritis (2014) (8)
Polymorphisms in the interleukin 4, interleukin 13 and corresponding receptor genes are not associated with Systemic Sclerosis and do not influence gene expression (2010) (8)
[Otorhinolaryngological manifestations in patients with Behçet disease]. (2014) (8)
Pulse wave velocity and augmentation index are not independently associated with carotid atherosclerosis in patients with rheumatoid arthritis (2017) (8)
Clinical guidelines: Best practices and uncertainties in the management of PMR (2016) (8)
The presence of both HLA-DRB1[*]04:01 and HLA-B[*]15:01 increases the susceptibility to cranial and extracranial giant cell arteritis. (2021) (7)
Implication of osteoprotegerin and sclerostin in axial spondyloarthritis cardiovascular disease: study of 163 Spanish patients. (2018) (7)
Reappraisal of the 1990 American College of Rheumatology criteria for the classification of cutaneous vasculitis: an analysis based on 766 patients. (2014) (7)
Tocilizumab in Behçet's disease with refractory ocular and/or neurological involvement: response according to different clinical phenotypes. (2021) (7)
FGF23-Klotho axis in patients with rheumatoid arthritis. (2019) (7)
Coexistence of Hidradenitis Suppurativa with Autoimmune Thyroiditis: Report of Three Cases (2015) (7)
[Dyslipidemia in patients with rheumatoid arthritis]. (2016) (7)
Proprotein convertase subtilisin/kexin type 9 in the dyslipidaemia of patients with axial spondyloarthritis is related to disease activity. (2020) (7)
IGF-1 and ADMA Levels Are Inversely Correlated in Nondiabetic Ankylosing Spondylitis Patients Undergoing Anti-TNF-Alpha Therapy (2014) (7)
Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies. (2022) (7)
HLA association with the susceptibility to anti-synthetase syndrome. (2020) (7)
Body Mass Index and Disease Activity in Chronic Inflammatory Rheumatic Diseases: Results of the Cardiovascular in Rheumatology (Carma) Project (2020) (7)
Amylin in the insulin resistance of patients with rheumatoid arthritis. (2018) (7)
Contribution of HLA-DRB1 shared epitope alleles and chronic inflammation to the increased incidence of cardiovascular disease in rheumatoid arthritis: comment on the article by Farragher et al. (2008) (7)
Leveraging Genetic Findings for Precision Medicine in Vasculitis (2019) (7)
Corrigendum: Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus (2011) (7)
Regulated upon activation normal T-cell expressed and secreted (RANTES) and epithelial cell-derived neutrophil-activating peptide (ENA-78) gene polymorphisms in patients with biopsy-proven erythema nodosum. (2009) (7)
HLA-DRB 1 association with Henoch-Schonlein purpura (2014) (7)
Endothelial Progenitor Cells: Relevant Players in the Vasculopathy and Lung Fibrosis Associated with the Presence of Interstitial Lung Disease in Systemic Sclerosis Patients (2021) (7)
Autoantibodies and biomarkers of endothelial cell activation in atherosclerosis. (2014) (7)
Lack of association between the CXCL12 rs501120 polymorphism and cardiovascular disease in Spanish patients with rheumatoid arthritis. (2012) (7)
Interleukin-1 beta gene polymorphism in patients with biopsy-proven erythema nodosum. (2011) (7)
HLA-B 35 Association with Nephritis in Henoch-Schönlein Purpura (2004) (7)
Lack of association between RETN rs1862513 polymorphism and cardiovascular disease in rheumatoid arthritis patients. (2011) (7)
Long-term survival of lung transplantation for interstitial lung disease associated with connective tissue diseases: a study of 26 cases from a referral centre. (2019) (7)
Carotid Plaque Assessment Reclassifies Patients with Inflammatory Bowel Disease into Very-High Cardiovascular Risk (2021) (6)
Monomeric C reactive protein (mCRP) regulates inflammatory responses in human and mouse chondrocytes (2021) (6)
Lack of association between IFNGR 1 gene polymorphisms and biopsy-proven giant cell arteritis (2006) (6)
Septic discitis as initial manifestation of streptococcus bovis endocarditis. (2006) (6)
Lack of Association Between STAT4 Gene Polymorphism and Biopsy-proven Giant Cell Arteritis (2009) (6)
Lack of association between carotid intima-media wall thickness and carotid plaques and markers of endothelial cell activation in rheumatoid arthritis patients undergoing anti-TNF therapy. (2012) (6)
Immune-related adverse events in patients with solid-organ tumours treated with immunotherapy: a 3-year study of 102 cases from a single centre. (2020) (6)
Lack of Association between JAK3 Gene Polymorphisms and Cardiovascular Disease in Spanish Patients with Rheumatoid Arthritis (2015) (6)
Consideration of Antisynthetase Syndrome Features in Classifying Patients as Having Idiopathic Inflammatory Myopathy: Comment on the Article by Lundberg et al (2018) (6)
Subclinical atherosclerosis is not increased in patients with non-radiographic axial spondyloarthritis. (2016) (6)
Managing of giant cell arteritis and polymyalgia rheumatica (2016) (6)
Beta Cell Function is Disrupted in Patients with Systemic Lupus Erythematosus. (2020) (6)
Identification of a shared genetic risk locus for Kawasaki disease and IgA vasculitis by a cross-phenotype meta-analysis. (2021) (6)
[Septic arthritis from Streptococcus pneumoniae in rheumatoid arthritis]. (1992) (6)
Analysis of two autoimmunity genes, IRAK1 and MECP2, in giant cell arteritis. (2014) (6)
Implication of CXCL5 (epithelial neutrophil-activating peptide 78) in the development of insulin resistance in patients with rheumatoid arthritis. (2018) (6)
The Number of Traditional Cardiovascular Risk Factors Is Independently Correlated with Disease Activity in Patients with Psoriatic Arthritis (2020) (6)
Response to 'Infliximab therapy increases body fat mass in early rheumatoid arthritis independently of changes in disease activity and levels of leptin and adiponectin: a randomized study over 21 months' (2011) (6)
Treating multidrug‐resistant psoriasis with brodalumab, apremilast, methotrexate and prednisone combination therapy in the COVID‐19 pandemic (2020) (5)
Enhanced Cardiovascular Risk in Rheumatoid Arthritis: Elucidation, Assessment, and Management (2015) (5)
Evaluation of a Shared Autoimmune Disease-associated Polymorphism of TRAF6 in Systemic Sclerosis and Giant Cell Arteritis (2012) (5)
Corrigendum: Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategy (2017) (5)
Higher Prevalence and Degree of Insulin Resistance in Patients With Rheumatoid Arthritis Than in Patients With Systemic Lupus Erythematosus (2020) (5)
HLA–B*08 Identified as the Most Prominently Associated Major Histocompatibility Complex Locus for Anti–Carbamylated Protein Antibody–Positive/Anti–Cyclic Citrullinated Peptide–Negative Rheumatoid Arthritis (2021) (5)
Lack of association between IL6 gene and Henoch-Schönlein purpura. (2014) (5)
Genetic Basis of Vasculitides with Neurologic Involvement. (2019) (5)
Dickkopf-3 (DKK3) Signaling in IL-1α-Challenged Chondrocytes: Involvement of the NF-κB Pathway (2020) (5)
Moderate and High Disease Activity Predicts the Development of Carotid Plaque in Rheumatoid Arthritis Patients without Classic Cardiovascular Risk Factors: Six Years Follow-Up Study (2021) (5)
Interleukin-6 promoter polymorphism at position -174 in biopsy-proven patients with erythema nodosum from a defined population. (2008) (5)
Vaspin in atherosclerotic disease and cardiovascular risk in axial spondyloarthritis: a genetic and serological study (2021) (5)
A case-control study suggests that the CCR6 locus is not involved in the susceptibility to giant cell arteritis. (2013) (5)
The search for improvement in the sensitivity of temporal artery biopsy in giant cell arteritis. (2015) (5)
Toll-like receptor 4 Asp299Gly polymorphism and rheumatoid arthritis: a replicative study in three different populations (2005) (5)
Potential role of mitral valve strands on stroke recurrence in rheumatoid arthritis. (2003) (5)
HLA-B*08 identified as the most associated MHC locus for anti-carbamylated protein antibody-positive/anti-CCP-negative rheumatoid arthritis. (2020) (5)
The influence of inflammation in the development of subclinical atherosclerosis in psoriatic arthritis: comment on ‘Cardiovascular comorbidities in patients with psoriatic arthritis: a systematic review’ by Jamnistki et al (2014) (5)
A Nonsynonymous Functional Variant of the ITGAM Gene Is Not Involved in Biopsy-proven Giant Cell Arteritis (2011) (5)
Fc receptor gamma subunit polymorphisms and systemic lupus erythematosus. (2004) (5)
QRISK3 Relation to Carotid Plaque is Higher than that of SCORE In Patients with Systemic Lupus Erythematosus. (2021) (5)
An international audit of the management of dyslipidaemia and hypertension in patients with rheumatoid arthritis-results from 19 countries. (2021) (5)
Irisin as a Novel Biomarker of Subclinical Atherosclerosis, Cardiovascular Risk and Severe Disease in Axial Spondyloarthritis (2022) (5)
Libman-sacks endocarditis and primary antiphospholipid syndrome. (2005) (5)
Sclerostin serum levels in patients with systemic autoimmune diseases. (2016) (5)
Telomere length, endothelial activation and carotid atherosclerosis in black and white African patients with rheumatoid arthritis. (2016) (4)
Endothelial nitric oxide synthase polymorphisms in biopsy-proven erythema nodosum from a defined population. (2007) (4)
Systemic vasculitides. (2002) (4)
Evaluation of serum omentin-1 and apelin concentrations in patients with hidradenitis suppurativa (2021) (4)
Key Molecules of Triglycerides Pathway Metabolism Are Disturbed in Patients With Systemic Lupus Erythematosus (2022) (4)
Lack of association of epithelial cell-derived neurophil-activating peptide (ENA)-78 gene polymorphism with susceptibility to biopsy-proven giant cell arteritis. (2007) (4)
The pros and cons of intravenous immunoglobulin treatment in autoimmune nephropathy. (2004) (4)
Rheumatoid arthritis and anti-TNF-α therapy (2005) (4)
Autoimmune disease-associated CD226 gene variants are not involved in giant cell arteritis susceptibility in the Spanish population. (2012) (4)
Interleukin 1 receptor antagonist relation to cardiovascular disease risk in patients with rheumatoid arthritis (2022) (4)
No evidence of association of the KLF12 gene with rheumatoid arthritis in Spanish and Dutch cohorts and a meta-analysis of published data. (2011) (4)
Interstitial keratitis secondary to severe hidradenitis suppurativa responding to adalimumab. (2012) (4)
Biologic Therapy in COVID-19 (2020) (4)
Audiovestibular Manifestations in Systemic Vasculitis: An Update (2011) (4)
Implication of new atherosclerotic carotid plaques in the cardiovascular outcome of patients with rheumatoid arthritis (2012) (4)
Long-term rheumatoid arthritis and endothelial dysfunction. (2004) (4)
Effects of disease activity on lipoprotein levels in patients with early arthritis: can oxidized LDL cholesterol explain the lipid paradox theory? (2020) (4)
[Arthritis reactive to Giardia lamblia]. (1992) (4)
The Functional Polymorphism 844 A>G in FcαRI (CD89) Does Not Contribute to Systemic Sclerosis or Rheumatoid Arthritis Susceptibility (2011) (4)
OP0339 TOCILIZUMAB IN GIANT CELL ARTERITIS. MONOTHERAPY VERSUS COMBINED WITH CONVENTIONAL IMMUNOSUPPRESSIVE DRUGS (2019) (4)
Subclinical aortitis after starting nivolumab in a patient with metastatic melanoma. A case of drug-associated aortitis? (2018) (4)
HLA-DRB1 associations in biopsy proven erythema nodosum. (2001) (4)
Role of VEGF Polymorphisms in the Susceptibility and Severity of Interstitial Lung Disease (2021) (4)
[Behcet syndrome and peripheral neuropathy as a possible new minor criterion]. (1991) (4)
articleA 1298 C polymorphism in the MTHFR gene predisposes to cardiovascular risk in rheumatoid arthritis (2010) (4)
Role of asymptomatic hyperuricemia and serum uric acid levels in the pathogenesis of subclinical atherosclerosis in psoriatic arthritis: comment on the article by Chen et al. (2009) (4)
Role of BANK1 Gene Polymorphisms in Biopsy-proven Giant Cell Arteritis (2010) (4)
Association of FCGR 2 A and FCGR 2 A-FCGR 3 A haplotypes with susceptibility to giant cell arteritis (2015) (4)
[Collagenous colitis associated with rheumatoid arthritis]. (1991) (4)
Identi fi cation of the PTPN 22 functional variant R 620 W as susceptibility genetic factor for giant cell arteritis (2013) (4)
Relative Risk Chart Score for the Assessment of the Cardiovascular Risk in Young Patients with Ankylosing Spondylitis (2018) (4)
Correction: Identification of Novel Genetic Markers Associated with Clinical Phenotypes of Systemic Sclerosis through a Genome-Wide Association Strategy (2011) (3)
The role of a functional variant of TYK2 in vasculitides and infections. (2020) (3)
Dysfunction of myoplasmic Ca2+ regulation in skeletal muscle from predialytic uremic patients. (1995) (3)
Investigation of TLR 5 and TLR 7 as candidate genes for susceptibility to systemic lupus erythematosus (2006) (3)
Prevalence of Comorbidities in Rheumatoid Arthritis and Evaluation of Their Monitoring in Clinical Practice: The Spanish Cohort of the COMORA Study (2019) (3)
Cardiovascular and disease-related features associated with extra-articular manifestations in axial spondyloarthritis. A multicenter study of 888 patients. (2022) (3)
[Neuro-Behçet: a follow-up of 4 cases treated with chlorambucil]. (1995) (3)
Additional proposals to reduce comorbidity in patients with chronic inflammatory rheumatic diseases: comment on ‘Points to consider for reporting, screening for and preventing selected comorbidities in chronic inflammatory rheumatic diseases in daily practice: a EULAR initiative’ by Baillet et al (2016) (3)
[Ear, nose and throat manifestations of Wegener's granulomatosis (granulomatosis with polyangiitis)]. (2012) (3)
Low back pain as presenting manifestation of giant cell arteritis associated to abdominal aortitis. (2007) (3)
Single-nucleotide polymorphisms at the 9p21.3 genomic region not associated with the risk of cardiovascular disease in patients with rheumatoid arthritis. (2013) (3)
Analysis of six tetranucleotide polymorphisms of the X-chromosome in different Spanish regions (2006) (3)
A TNFSF13B functional variant is not involved in systemic sclerosis and giant cell arteritis susceptibility (2018) (3)
Endothelin-1 serum levels in women with Rheumatoid Arthritis. (2019) (3)
Lack of association between ICAM-1 gene polymorphisms and biopsy-proven erythema nodosum. (2004) (3)
[Reactive arthritis and infestation by Giardia lamblia]. (1991) (3)
Experts document on methotrexate use in combined therapy with biological or targeted synthetic disease modifying drugs in patients with rheumatoid arthritis. (2020) (3)
Rituximab in Takayasu arteritis: an unmet hope. (2018) (3)
Machine Learning for the Identification of a Common Signature for Anti–SSA/Ro 60 Antibody Expression Across Autoimmune Diseases (2022) (3)
THU0219 Beneficial effect of anti-il-6 blockade on insulin resistance and insulin sensitivity in patients with rheumatoid arthritis (2018) (3)
Validation of the Spanish version of the fibromyalgia rapid screening tool to detect fibromyalgia in primary care health centres. (2016) (3)
The role of PET/CT in the evaluation of patients with large-vessel vasculitis: useful for diagnosis but with potential limitations for follow-up. (2022) (2)
Disparate results in studies of adalimumab in the treatment of hidradenitis suppurativa: comment on the article by Amano et al (2013) (2)
The impact of the metabolic syndrome on cardiovascular risk and disease in rheumatoid arthritis (2008) (2)
FRI0612 IMMUNE-RELATED ADVERSE EVENTS ASSOCIATED WITH IMMUNOTHERAPY. LONG-TERM FOLLOW-UP OF 102 PATIENTS FROM A REFERRAL SINGLE CENTER (2019) (2)
THU0087 Subclinical Carotid Atherosclerosis in Rheumatoid Arthritis: Role of Serum Cathepsin S and Cystatin C (2016) (2)
Functional Variants of Fc Gamma Receptor (FCGR2A) and FCGR3AAre Not Associated with Susceptibility to Systemic Sclerosis in a Large European Study (EUSTAR) (2011) (2)
Amylin serum levels are upregulated in patients with systemic lupus erythematosus. (2021) (2)
Lack of Association Between IRF5 Gene Polymorphisms and Biopsy-proven Giant Cell Arteritis (2010) (2)
Misperception of the Cardiovascular Risk in Patients with Rheumatoid Arthritis (2020) (2)
Influence of IL17A gene on the pathogenesis of immunoglobulin-A vasculitis. (2020) (2)
BAFF, APRIL and BAFFR on the pathogenesis of Immunoglobulin-A vasculitis (2021) (2)
The angiopoietin-like protein 4, apolipoprotein C3, and lipoprotein lipase axis is disrupted in patients with rheumatoid arthritis (2022) (2)
Lack of association between flow-mediated endothelium-dependent vasodilatation and biomarkers of endothelial dysfunction in patients with severe rheumatoid arthritis (2012) (2)
HLA-DRB1 associations in systemic lupus erythematosus patients from northwest Spain. (2001) (2)
Osteopontin and interleukin-6 as biomarkers of interstitial lung disease (2020) (2)
Association study of BAK1 gene polymorphisms in Spanish rheumatoid arthritis and systemic lupus erythematosus cohorts (2011) (2)
SAT0127 The efficacy of tofacitinib in patients with rheumatoid arthritis stratified by baseline body mass index (2018) (2)
Vascular endothelial growth factor haplotypes are associated with severe ischaemic complications in giant cell arteritis regardless of the disease phenotype. (2021) (2)
Role of carotid ultrasonography in the evaluation of cardiovascular risk in patients with rheumatoid arthritis (2010) (2)
CXCL5 gene polymorphism association with diabetes mellitus. (2008) (2)
Lack of association between IFNGR1 gene polymorphisms and biopsy-proven giant cell arteritis. (2010) (2)
Insulin Resistance Is Not Increased in Inflammatory Bowel Disease Patients but Is Related to Non-Alcoholic Fatty Liver Disease (2021) (2)
Erratum to “Cardiovascular morbidity and associated risk factors in Spanish patients with chronic inflammatory rheumatic diseases attending rheumatology clinics: Baseline data of the CARMA Project” [Semin Arthritis Rheum 44 (2015) 618–626] (2015) (2)
Biologic Therapy in Refractory Non-Multiple Sclerosis Optic Neuritis Isolated or Associated to Immune-Mediated Inflammatory Diseases. A Multicenter Study (2020) (2)
Association of STAT4 gene with rheumatoid arthritis (2008) (2)
Etanercept-induced hypertriglyceridemia during the treatment of recurrent aphthous stomatitis. (2013) (2)
Role of MUC1 rs4072037 polymorphism and serum KL-6 levels in patients with antisynthetase syndrome (2021) (2)
Potential relation of cardiovascular risk factors to disease activity in patients with axial spondyloarthritis (2021) (2)
Influence of IL2RA rs2104286 Polymorphism in the Risk of Biopsy-proven Giant Cell Arteritis (2010) (2)
Rheumatoid arthritis and anti-TNF-alpha therapy. (2005) (2)
Association Between Homocysteine Serum Level and Bone Mineral Density in Patients With Rheumatoid Arthritis. (2019) (2)
Obesity and response to biological therapy in rheumatoid arthritis: the role of body mass index and adipose tissue cytokines. (2021) (2)
Intravenous methylprednisolone induces rapid improvement in non-infectious uveitis: a multicentre study of 112 patients. (2021) (2)
Asprosin in health and disease, a new glucose sensor with central and peripheral metabolic effects (2023) (2)
E064 The relationship between lipid profile changes and inflammation across the Phase 3 sarilumab rheumatoid arthritis (RA) development programme (2019) (2)
Role of the IL33 and IL1RL1 pathway in the pathogenesis of Immunoglobulin A vasculitis (2021) (2)
H2-A polymorphism contributes to H2-Eβ-mediated protection in collagen-induced arthritis (2007) (2)
ESICM LIVES 2016: part one (2016) (2)
Association of apolipoprotein B/apolipoprotein A1 ratio and cardiovascular events in rheumatoid arthritis: results of the CARMA study. (2019) (2)
Histopathologic differences between cutaneous vasculitis associated with severe bacterial infection and cutaneous vasculitis secondary to other causes: study of 52 patients. (2016) (2)
Predicting the risk of relapse in polymyalgia rheumatica: novel insights (2021) (2)
H2-A polymorphism contributes to H2-Eβ-mediated protection in collagen-induced arthritis (1996) (2)
Idiopathic chronic polyserositis with massive ascites responding to colchicine in an adult: A case report (2014) (2)
Role of fibroblast growth factor-23 in calcinosis in women with systemic sclerosis. (2020) (2)
Vitamin D levels and response to biphosphonates in postmenopausal women receiving glucocorticoid therapy (2014) (2)
The Performance of Vascular Age in the Assessment of Cardiovascular Risk of Patients with Rheumatoid Arthritis (2020) (2)
Analysis of the influence of the ghrelin receptor rs509035, rs512692 and rs2922126 polymorphisms in the risk of cardiovascular disease in patients with rheumatoid arthritis. (2011) (2)
Comparable effects of traditional cardiovascular risk factors on subclinical atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis. (2020) (2)
Interleukin-1 receptor antagonist gene polymorphism in patients with biopsy-proven erythema nodosum. (2010) (1)
Lack of Association Between TLR 4 rs 4986790 Polymorphism and Risk of Cardiovascular Disease in Patients with Rheumatoid Arthritis (2012) (1)
AB0293 ASSOCIATION OF HOMOCYSTEINE WITH BONE MINERAL DENSITY IN RHEUMATOID ARTHRITIS PATIENTS (2019) (1)
The use of carotid ultrasonography in the assessment of subclinical atherosclerosis and the paradoxical effect of corticosteroids on atherosclerosis in patients with rheumatoid arthritis. (2009) (1)
Why is Rheumatoid Arthritis Mortality Still High Despite the Advent of New Therapies? Comment on the Article by Widdifield et al (2016) (1)
Cardiovascular risk assessment in rheumatoid arthritis: What goals should be achieved? (2015) (1)
Respiratory syncytial virus infection in a patient with systemic lupus erythematosus (1994) (1)
[Seronegative systemic lupus erythematosus and autoimmune thyroiditis]. (1993) (1)
Pleural and pericardial effusion as the only manifestation of IgG4-related disease (2020) (1)
Disease activity in patients with rheumatoid arthritis increases serum levels of apolipoprotein C-III. (2021) (1)
Response to ‘Adipokines, inflammation, insulin resistance, and carotid atherosclerosis in patients with rheumatoid arthritis’ (2014) (1)
SAT0170 Anti-il-6 therapy modulates leptin in patients with rheumatoid arthritis (2018) (1)
[Paraneoplastic polyarthritis. Description of 5 cases]. (1987) (1)
SAT0540 Treatment with intravenous immunoglobulin in the vasculitis anca positive. 27 cases studied in a single reference centre (2018) (1)
Targeted nanotherapy with everolimus reduces inflammation and fibrosis in scleroderma‐related interstitial lung disease developed by PSGL‐1 deficient mice (2022) (1)
FRI0452 Nailfold capillaroscopy in antisynthetase syndrome (NASCAR): results of a multicenter, international study of the american and european network of antisynthetase syndrome (AENEAS) (2018) (1)
Is the Homeostatic Model Assessment of Insulin Resistance a Poor Predictor of Cardiovascular Disease in Rheumatoid Arthritis? Comment on the Article by Giles et al (2015) (1)
Positron emission tomography/computed tomography in relapsing polychondritis. (2020) (1)
IgA Vasculitis (Henoch-Schönlein Purpura) (2014) (1)
AB0730 RECLASSIFICATION INTO VERY HIGH CARDIOVASCULAR RISK AFTER CAROTID ULTRASOUND IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS (2019) (1)
Lack of Association Between the rs6920220 (G/A) Polymorphism of the 6q23 Region and Biopsy-proven Giant Cell Arteritis (2010) (1)
[Cardiovascular disease in rheumatoid arthritis. Importance and clinical management]. (2009) (1)
SAT0220 USE OF TOCILIZUMAB IN AORTITIS. A MULTICENTER STUDY OF 79 PATIENTS (2019) (1)
Apolipoprotein C-III in patients with systemic lupus erythematosus (2022) (1)
Serum Levels of Transforming Growth Factor Beta 1 in Systemic Lupus Erythematosus Patients (2022) (1)
QRISK3 Performance in the Assessment of Cardiovascular Risk in Patients with Inflammatory Bowel Disease (2021) (1)
[Post-streptococcal reactive arthritis versus rheumatic fever]. (1992) (1)
Rheumatoid arthritis-etiology, pathogenesis and animal models (1)
[Adult-onset Still's disease]. (2016) (1)
Carotid ultrasound as predictor of atherosclerosis in rheumatoid arthritis. (2012) (1)
Implication of CXCL 5 ( epithelial neutrophil-activating peptide 78 ) in the development of insulin resistance in patients with rheumatoid arthritis (2019) (1)
AB0577 TOCILIZUMAB IN GIANT CELL ARTERITIS. ROUTE OF ADMINISTRACION: INTRAVENOUS OR SUBCUTANEOUS (2019) (1)
O31 Integrative analysis reveals a molecular stratification of systemic autoimmune diseases (2020) (1)
Elevated VCAM-1, MCP-1 and ADMA serum levels related to pulmonary fibrosis of interstitial lung disease associated with rheumatoid arthritis (2022) (1)
P235 Glucocorticoid dose is progressively reduced in Patients with rheumatoid arthritis (RA) receiving sarilumab: results from the open label EXTEND study (2020) (1)
Gastrointestinal involvement in adult IGA vasculitis. (2020) (1)
Management of Cardiovascular Disease Risk in Rheumatoid Arthritis (2022) (1)
Association between homocysteine levels and arterial stiffness in women with systemic sclerosis. (2020) (1)
Apolipoprotein C3 and beta-cell dysfunction are linked in patients with systemic lupus erythematosus. (2021) (1)
A Review of the Dermatological Complications of Giant Cell Arteritis (2021) (1)
Re: Autoimmunity in sudden sensorineural hearing loss… by Cadoni et al (2003) (1)
Lack of association between RETN rs 1862513 polymorphism and cardiovascular disease in patients with rheumatoid arthritis (2006) (1)
Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis (2022) (1)
Remission in palindromic rheumatism during pregnancy. (1993) (1)
[Comparative study of von Willebrand factor in patients with temporal arteritis]. (1992) (1)
THU0288 LONG-TERM FOLLOW-UP OF ANTI-IL6-RECEPTOR TOCILIZUMAB IN REFRACTORY UVEITIS IN PATIENTS WITH BEHÇET’S DISEASE. MULTICENTER STUDY OF 14 PATIENTS IN CLINICAL PRACTICE (2019) (1)
Apolipoprotein C3 Is Downregulated in Patients With Inflammatory Bowel Disease (2022) (1)
Detection of high cardiovascular risk patients with ankylosing spondylitis based on the assessment of abdominal aortic calcium as compared to carotid ultrasound (2018) (1)
Altitude and giant cell arteritis. (2005) (1)
SAT0535 Carotid Ultrasound in The Cardiovascular Risk Stratification of Patients with Ankylosing Spondylitis: Results of A Population-Based Study (2016) (1)
Long-term survival of renal transplantation in patients with lupus nephritis: experience from a single university centre. (2021) (1)
Serum leptin concentration is associated with the attainment of clinical outcomes in patients with axial spondyloarthritis treated with TNF inhibitors. (2022) (1)
Atherosclerosis in ankylosing spondylitis: clinical implications. (2018) (1)
FRI0604 SYSTEMIC SARCOIDOSIS. STUDY OF 381 PATIENTS FROM A TERTIARY UNIVERSITY HOSPITAL IN THE NORTH OF SPAIN (2019) (1)
Alpha-Klotho protein in systemic lupus erythematosus. (2021) (1)
THU0282 The impact of comorbidities on physical function in patients with ankylosing spondylitis (AS) and psoriatic arthritis (PSA) attending rheumatology clinics (2018) (1)
SCORE2 Assessment in the Calculation of Cardiovascular Risk in Patients with Rheumatoid Arthritis (2021) (1)
Experts document on methotrexate use in combined therapy with biological or targeted synthetic disease modifying drugs in patients with rheumatoid arthritis. (2022) (1)
THU0121 CIRCULATING FIBROBLAST GROWTH FACTOR-23 IS ASSOCIATED WITH DYSLIPIDEMIA IN RHEUMATOID ARTHRITIS PATIENTS (2019) (0)
THU0224 Anti-TNF-α Therapy Reduces Endothelial Cell Activation in Non-Diabetic Ankylosing Spondylitis Patients (2015) (0)
Tocilizumab for rheumatoid arthritis: results of the Phase III clinical trial program (2011) (0)
SAT0063 ASSOCIATION OF SMOKING WITH TRIPLE CONCORDANT SEROPOSITIVITY IN RA PATIENTS, AND WITH RHEUMATOID FACTOR IN THE REMAINING PATIENTS (2019) (0)
Lymphocytes Overexpressing Human Bcl-2 in T Autoimmunity in Transgenic Mice T Cell-Dependent Inhibition of + CD 25 + CD 4 Izui (2007) (0)
Efficacy of tofacitinib in patients with rheumatoid arthritis stratified by baseline body mass index: an analysis of pooled data from phase 3 studies (2022) (0)
FRI0253 RENAL TRANSPLANTATION IN LUPUS NEPHRITISVS NON-AUTOIMMUNE TRANSPLANTATION. LONG TERM FOLLOW-UP. STUDY FROM A SINGLE TERTIARY CENTER (2019) (0)
THU0566 OCULAR FEATURES IN 381 PATIENTS WITH SYSTEMIC SARCOIDOSIS AND ITS CORRELATION WITH THE IWOS CRITERIA. STUDY IN A UNIVERSITY HOSPITAL (2019) (0)
SAT0081 Lack of Correlation Between Carotid Ultrasound and Disease Duration or Specific Features of Rheumatoid Arthritis (2015) (0)
Point of view about biologic therapy in covid-19 (2020) (0)
[Lupus myopathy refractory to steroid treatment]. (1991) (0)
A185 Infrared thermal imaging of the hand during vascular occlusion in healthy volunteers (2016) (0)
Cefuroxime axetil in the treatment of lower respiratory tract infections in patients with chronic lung diseases (1992) (0)
THU0340 Rheumatoid Arthritis and Systemic Lupus Erythematosus Exhibit Similar Degree of Severity of Subclinical Atherosclerosis. Results from A Cross-Sectional Study in A Population of Northwestern Spain (2016) (0)
Correction: SMAD3 rs17228212 Gene Polymorphism Is Associated with Reduced Risk to Cerebrovascular Accidents and Subclinical Atherosclerosis in Anti-CCP Negative Spanish Rheumatoid Arthritis Patients (2013) (0)
Association of circulating calprotectin with lipid profile in axial spondyloarthritis (2018) (0)
SAT0348 CLINICAL SPECTRUM TIME COURSE OF ANTISYNTHETASE SYNDROME PATIENTS POSITIVE FOR ANTICENTROMERE ANTIBODIES (2020) (0)
The genetic contribution of inflammation to the increased risk of cardiovascular disease in rheumatoid arthritis. (2023) (0)
University of Groningen Identification of Novel Genetic Markers Associated with Clinical Phenotypes of Systemic Sclerosis through a Genome-Wide Association Strategy Gorlova, (2011) (0)
A Proof-of-Concept Analysis of Plasma-Derived Exosomal microRNAs in Interstitial Pulmonary Fibrosis Secondary to Antisynthetase Syndrome (2022) (0)
[Meningococcal arthritis. Clinical presentation and serologic characteristics in 13 patients]. (1986) (0)
WISP-2 modulates the induction of inflammatory mediators and cartilage catabolism in chondrocytes (2022) (0)
SAT0346 Cutaneous Vasculitis Associated To Connective Tissue Diseases and Other Autoimmune Disorders. Study of 35 Patients from A Single Centre (2016) (0)
Compared efficacy of rituximab, abatacept, and tocilizumab in patients with rheumatoid arthritis refractory to methotrexate or anti-TNF agents: a systematic review and network (2021) (0)
[Adult Schonlein-Henoch syndrome with abdominal involvement refractory to steroid treatment]. (1990) (0)
SAT0012 Proteinase K-Like Serine Protease PCSK9 Influence on the Dyslipidemia Observed in Rheumatoid Arthritis Patients (2015) (0)
OP0169 LONG-TERM SURVIVAL IN LUNG TRANSPLANTATION FOR INTERSTITIAL LUNG DISEASE ASSOCIATED WITH CONECTIVE TISSUE DISEASES. STUDY OF 26 CASES OF A SINGLE CENTER (2019) (0)
AB0755 Urticarial vasculitis: A clinical and histopathologic review (2013) (0)
AB0316 Bone Mass, Osteoprotegerin and Vitamin D: Relation with Endothelial Dysfunction in Rheumatoid Arthritis Patients (2014) (0)
WISP-2 modulates the induction of inflammatory mediators and cartilage catabolism in chondrocytes. (2022) (0)
AB1301 Cardiovascular risk age and vascular age estimations in predicting cardiovascular events in rheumatoid arthritis patients (2018) (0)
THU0081 Role of The Soluble Form of Dipeptydil Peptidase-4(DPP4) in The Insulin Resistance of Patients with Rheumatoid Arthritis (2016) (0)
Treatment of migraine with monoclonal antibodies (2022) (0)
FRI0477 SYSTEMIC TREATMENT IN SARCOIDOSIS. STUDY OF 377 PATIENTS FROM A SINGLE UNIVERSITY HOSPITAL (2020) (0)
SAT0119 Comparison between Carotid Plaque and Carotid Intima Media Thickness To Detect Subclinical Atherosclerosis in Rheumatoid Arthritis (2016) (0)
IgA Vasculitis: Influence of CD40, BLK and BANK1 Gene Polymorphisms (2022) (0)
Acknowledgement to referees (2016) (0)
AB0151 Factors associated with serum IL-6 levels in patients with early arthritis (2013) (0)
[Paraneoplastic arthritis as the first manifestation of a hypernephroma]. (1992) (0)
Cranial and extracranial large-vessel giant cell arteritis share a genetic pattern of interferon-gamma pathway. (2022) (0)
A predominant involvement of the triple seropositive patients and others with rheumatoid factor in the association of smoking with rheumatoid arthritis (2020) (0)
AB1098 COMPARISON OF THE PERFORMANCE OF CLASSIFICATION/DIAGNOSTIC CRITERIA FOR POLYMYALGIA RHEUMATICA. SINGLE CENTERSTUDY OF 100 PATIENTS (2019) (0)
A genome-wide association study suggests the HLA Class II region as the major susceptibility locus for IgA vasculitis (2017) (0)
FRI0277 ISCHEMIC AND SYSTEMIC SYMPTOMS IN GIANT CELL ARTERITIS PATIENTS, RESPONSE TO TOCILIZUMAB (2019) (0)
Progranulin in Musculoskeletal Inflammatory and Degenerative Disorders, Focus on Rheumatoid Arthritis, Lupus and Intervertebral Disc Disease: A Systematic Review (2022) (0)
FRI0291 RENAL TRANSPLANTATION DUE TO RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS (RPGN). COMPARATIVE STUDY WITH NON-AUTOIMMUNE TRANSPLANTATION AND LONG-TERM FOLLOW-UP. STUDY FROM A SINGLE TERTIARY CENTER (2019) (0)
Transforming growth factor beta 1 is associated with subclinical carotid atherosclerosis in patients with systemic lupus erythematosus (2023) (0)
A CROSS-DISEASE META-GWAS IDENTIFIES IRF1, STAT3 AND ZBTB9-BAK1 AS NEW SHARED SUSCEPTIBILITY LOCI IN SYSTEMIC SCLEROSIS AND CROHN¿S DISEASE (2019) (0)
Role of IRF5 in the pathogenesis of immunoglobulin-A vasculitis. (2020) (0)
Subclinical Atherosclerosis in Ankylosing Spondylitis (2011) (0)
Is the extracranial large vessel giant cell arteritis still missing from the new 2022 ACR/EULAR classification criteria? (2023) (0)
THU0438 Comparative study of infliximab versus adalimumab in refractory uveitis associated to cystoid macular oedemadue to behÇet’s disease. mulcitenter study of 40 cases (2018) (0)
Endothelial nitric oxide synthase polymorphisms in biopsy-proven erythema nodosum from a defi ned population (2006) (0)
A case-control study suggests that the CCR 6 locus is not involved in the susceptibility to giant cell arteritis (2006) (0)
AB0111 THE ROLE OF KLOTHO IN RHEUMATOID ARTHRITIS (2019) (0)
FRI0006 PROTECTIVE ROLE OF THE PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9) RS2495477 POLYMORPHISM IN PATIENTS WITH RHEUMATOID ARTHRITIS AND SUBCLINICAL ATHEROSCLEROSIS (2019) (0)
INFLAMMATION AND HOST RESPONSE TO INFECTION CARD8 rs2043211 (p.C10X) Polymorphism Is Not Associated with Disease Susceptibility or Cardiovascular Events in Spanish Rheumatoid Arthritis Patients (2012) (0)
SAT0491 Clinical features and complications in a large international cohort of antimda5 patients: a challenge for the future (2018) (0)
SAT0129 Kidney Function, Endothelial Activation and Atherosclerosis in Black and White Africans with Rheumatoid Arthritis (2015) (0)
Reply to: Comment on: Reclassification into very-high cardiovascular risk in psoriatic arthritis as well as axial spondyloarthritis. (2020) (0)
[Polyarteritis nodosa in a woman with temporal arteritis]. (1992) (0)
Severe microscopic polyangiitis limited to the skin. (2021) (0)
SAT0150 Cutaneous Vasculitis Secondary to Drugs. Descriptive Study of 232 Patients (2013) (0)
Publisher Correction: A predominant involvement of the triple seropositive patients and others with rheumatoid factor in the association of smoking with rheumatoid arthritis (2020) (0)
SAT0506 KAWASAKI DISEASE AND CARDIOVASCULAR OUTCOMES IN THE LAST 25 YEARS. STUDY OF 55 PATIENTS FROM A REFERAL HOSPITAL IN THE NORTH OF SPAIN (2019) (0)
[Pneumothorax in rheumatoid arthritis as a factor of poor prognosis]. (1991) (0)
AB0034 The C allele of the single nucleotide polymorphism RS2228145 in the IL6 receptor gene is associated with higher levels of serum oxidised LDL in early arthritis patients (2013) (0)
FRI0215 RESPONSE TO TOCILIZUMAB IN LARGE VESSEL VASCULITIS ACCORDING TO THE EXTENT OF BASELINE 18F-FDG VASCULAR UPTAKE (2020) (0)
Role of adiponectin in non-diabetic patients with rheumatoid arthritis undergoing anti-IL-6 therapy. (2021) (0)
Sex disparities in systemic lupus erythematosus in Northwestern Spain are not due to ethnic diversity (2015) (0)
[Common variable immunodeficiency and polyarthritis: a case report]. (1993) (0)
FRI0276 TIME OF DISEASE EVOLUTION AND EFFICACY OF TOCILIZUMAB IN GIANT CELL ARTERITIS (2019) (0)
FRI0038 HERPES ZOSTER IN RHEUMATOID ARTHRITIS. PROSPECTIVE SINGLE CENTER STUDY OF 390 RA PATIENTS FOR 5YEARS (2019) (0)
Endothelin-1 as a Biomarker of Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Associated with Autoimmune Diseases (2023) (0)
Apolipoprotein C-III is linked to the insulin resistance and beta-cell dysfunction that are present in rheumatoid arthritis (2022) (0)
Polymyalgia rheumatica: when should we suspect an underlying large vessel vasculitis? (2023) (0)
FRI0625 Different strategies to implement the eular guideline for cardiovascular risk management in daily practice (2018) (0)
Association of Human Leukocyte Antigens Class II Variants with Susceptibility to Hidradenitis Suppurativa in a Caucasian Spanish Population (2020) (0)
Images in clinical medicine. Cold hands associated with scleroderma. (2013) (0)
. 2 from Northwestern Spain C-Reactive Protein Gene Polymorphisms in Biopsy-proven Giant Cell Arteritis (2009) (0)
Full characterization of the three pathways of the complement system in patients with systemic lupus erythematosus (2023) (0)
Proprotein Convertase Subtilisin/Kexin Type 9 in the Inflammation-Related Dyslipidemia of Patients with Axial Spondyloarthritis is Related to Disease Activity. (2020) (0)
Immunochip data of four autoimmune diseases reveals novel single-disease and cross-phenotype associations Coeliac (2018) (0)
THU0056 Impaired beta cell signaling is present in non diabetic rheumatoid arthritis patients (2013) (0)
Correction: Ferraz-Amaro et al. SCORE2 Assessment in The Calculation of Cardiovascular Risk in Patients with Rheumatoid Arthritis. Diagnostics 2021, 11, 2363 (2022) (0)
Reply to comment on: Alpha-Klotho protein in systemic lupus erythematosus. (2023) (0)
Comment on: Proprotein convertase subtilisin/kexin type 9 in the dyslipidaemia of patients with axial spondyloarthritis is related to disease activity: reply. (2021) (0)
Variant for Rheumatoid Arthritis in the 1 p 13 . 2 Region R 620 W Polymorphism As the Sole Common Risk PTPN 22 Evidence for (2011) (0)
AB0007 The CD226 gene is not involved in giant cell arteritis in the spanish caucasian population (2013) (0)
AB0022 Influence of mhciita RS3087456 and RS4774 polymorphisms in the susceptibility to cardiovascular disease of patients with rheumatoid arthritis (2013) (0)
SAT0219 EFFICACY AND SAFETY OF TOCILIZUMAB IN GIANT CELL ARTERITIS INDEPENDENTLY OF THE INICIAL PREDNISONE DOSE (2019) (0)
Effect of cardiovascular disease on chronic inflammatory joint disease: reverse causality? (2020) (0)
Psoriasis of the external auditory canal: prevalence, clinical features and impact on quality of life (2022) (0)
¿Idiopathic pulmonary fibrosis or interstitial lung disease associated to connective tissue diseases? Endothelial progenitor cells as a potential tool for the differential diagnosis (2020) (0)
AB0277 Comparison between Intima-Media Thickness and Coronary Artery Tomography in Subclinical Atherosclerosis Detection in Rheumatoid Arthritis (2016) (0)
Vitamin D and autoimmune rheumatic diseases. (2016) (0)
Circulating interleukin-6 and cardiovascular disease risk in patients with rheumatoid arthritis with low disease activity due to active therapy. (2022) (0)
A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease (2020) (0)
AB0030 The LP13.3 genomic region -RS599839- is associated with endothelial dysfunction in patients with rheumatoid arthritis (2013) (0)
FRI0646 EFFECT OF LONG-TERM MEDIUM-DOSE STEROID TREATMENT ON 18F-FDG PET/CT FINDINGS TO ASSESS VASCULAR AND MUSCULOESKELETAL INVOLVEMENT IN PATIENTSWITH POLYMYALGIA REUMATICA (2019) (0)
[Usefulness of non-steroidal anti-inflammatory agents in the treatment of temporal arteritis]. (1992) (0)
No evidence for association between the CCR5/Delta32CCR5 polymorphism and systemic sclerosis. (2011) (0)
The of Rheumatology Are Not Associated with Susceptibility to Systemic Sclerosis in a Large European Correction: Functional Variants of Fc Gamma Receptor (FCGR2A) and FCGR3A (2010) (0)
Systemic Sclerosis susceptibility or phenotype polymorphism does not confirm association with -945 promoter CTGF A large multicenter analysis of (2009) (0)
Erratum to “Novel association of acid phosphatase locus 1*C allele with systemic lupus erythematosus” [Human Immunology 73 (2012) 107–110] (2012) (0)
Lack of association between endothelial nitric oxide synthase polymorphisms and cutaneous vasculitis (2003) (0)
Manifestations of Biopsy-proven Giant Cell Arteritis rs 1883832 Polymorphism in Susceptibility to and Clinical CD 40 Influence of 1 (2010) (0)
erythema nodosum. Lack of association between ICAM-1 gene polymorphisms and biopsy-proven (2017) (0)
Obesity and Osteoarthritis: Are Adipokines Bridging Metabolism, Inflammation, and Biomechanics? (2020) (0)
AB0093 Association of cd247 polymorphisms with rheumatoid arthritis: a replication study and a meta-analysis (2013) (0)
Serum Levels of Lipoprotein Lipase Are Increased in Patients with Inflammatory Bowel Disease (2023) (0)
THU0581 BIOLOGICAL THERAPY IN NON ISCHAEMIC OPTIC NEURITIS ASSOCIATED TO IMMUNE-MEDIATED INFLAMMATORY DISEASES. MULTICENTER STUDY (2019) (0)
SAT0124 MOLECULAR CHARACTERIZATION OF THE SERUM PROFILE ASSOCIATED TO THE INCREASED CARDIOVASCULAR RISK IN RHEUMATOID ARTHRITIS PATIENTS. EFFECTS OF BIOLOGICAL DRUGS. (2019) (0)
THU0079 HDL, IGG anti-HDL Antibodies and PON1 Axis in Rheumatoid Arthritis Patients: A New Target for CV Disease (2016) (0)
Chapter 24 Danazol Therapy (2008) (0)
[Churg-Strauss allergic granulomatous vasculitis: pulse therapy with cyclophosphamide as an alternative treatment]. (1991) (0)
THU0292 EXTRACRANIAL VESSEL INVOLVEMENT IN PATIENTS WITH GIANT CELL ARTERITIS (2019) (0)
FRI0322 INSULIN RESISTANCE IN NON-DIABETES PATIENTS WITH SPONDYLOARTHRITIS (2020) (0)
Heme oxygenase-1 promoter polymorphisms do not influence susceptibility to systemic sclerosis and its clinical phenotypes. (2013) (0)
SCORE2 versus SCORE in patients with systemic lupus erythematosus (2022) (0)
AB0612 TEMPORAL ARTERY BIOPSYIN GIANT CELL ARTERITIS. INTERRELATION OF INFLAMMATORY PATTERNS WITH ANALYTICAL DATA AND CLINICAL MANIFESTATIONS (2019) (0)
SAT0512 LONG-TERM FOLLOW-UP OF CARDIOVASCULAR OUTCOMES IN KAWASAKI DISEASE. OBSERVATIONAL STUDY FROM A SINGLE CENTER (2019) (0)
THU0584 RHEUMATOLOGICAL IMMUNE-RELATED ADVERSE EVENTS ASSOCIADTED WITH IMMUNOTHERAPY IN SOLID ORGAN TUMOR. STUDY OF 102 CASES FROM A REFERRAL SINGLE CENTER FOR LAST 4 YEARS (2019) (0)
LILRA3 deficiency is not involved in the giant cell arteritis and systemic sclerosis predisposition. (2016) (0)
Protein tyrosine phosphatase non-receptor 22 and C-Src tyrosine kinase genes are down-regulated in patients with rheumatoid arthritis (2017) (0)
FRI0050 Differential Expression of OPG/RANKL/TRAIL System in Rheumatoid Arthritis (2016) (0)
[Idiopathic granulomatous myopathy. An evolutionary study]. (1991) (0)
Chapter 13 Henoch-Schönlein Purpura (2007) (0)
AB0304 Utility of Relative Cardiovascular Risk and Vascular AGE in Reumathoid Arthritis Patients under 50 Years of Age (2014) (0)
AB0014 Lack of Association between AB0, PPAP2B, ADAMST7, PIK3CG, EDNRA and Carotid Intima-Media Thickness, Carotid Plaques and Cardiovascular Disease in Patients with Rheumatoid Arthritis (2014) (0)
Two coincidental neurological complications as a presenting form of infectious endocarditis. (2007) (0)
AB0242 SURVIVAL ANALYSIS IN THE DEVELOPMENT OF SERIOUS INFECTIONS AND SERIOUS RESPIRATORY INFECTIONS IN AR PATIENTS INCLUDED IN A VACCINATION PROGRAM (2020) (0)
Co-occurrence of giant cell arteritis in patients with polymyalgia rheumatica. Comment on the article by Nielsen AW, et al. (2022) (0)
SAT0120 Comparison between Carotid Ultrasonography and Coronary Artery Calcification Score To Detect Subclinical Atherosclerosis in Rheumatoid Arthritis (2016) (0)
THU0313 COMPARATIVE STUDY OF CLINICAL, ANALYTICAL AND VASCULAR 18F-FDG UPTAKE EVOLUTION IN PATIENTS WITH GIANT CELL ARTERITIS TREATED WITH METHOTREXATE VS TOCILIZUMAB (2019) (0)
Treatment With Tofacitinib in Refractory Psoriatic Arthritis: A National Multicenter Study of the First 87 Patients in Clinical Practice (2021) (0)
Omentin: a biomarker of cardiovascular risk in individuals with axial spondyloarthritis (2020) (0)
OP0304 GENETIC AND FUNCTIONAL STUDY OF OMENTIN REGARDING CARDIOVASCULAR RISK IN AXIAL SPONDYLOARTHRITIS (2019) (0)
Genome-wide pathway analysis identifies oxidative stress related gene MSRA as rheumatoid arthritis susceptibility locus (2010) (0)
SAT0568 PERSISTENT VASCULAR 18F-FDG UPTAKE DESPITE CLINICAL-ANALYTICAL REMISSION IN PATIENTS WITH LARGE VESSEL VASCULITIS UNDER TOCILIZUMAB THERAPY. SINGLE UNIVERSITARY CENTER EXPERIENCE OF 30 PATIENTS. (2020) (0)
AB0725 Anti-Tnf-α Therapy Improves Endothelial Function and Arterial Stiffness in Patients with Moderate-To-Severe Psoriasis: A 6-Month Prospective Study (2016) (0)
SAT0017 The C allele of RS2228145 polymorphism in the gene of IL6 receptor alpha chain may predict a worse clinical outcome in patients with early arthritis (2013) (0)
Cardiovascular disease in rheumatoid arthritis. Importance and clinical management (2009) (0)
Meta-analysis of Immunochip data of four autoimmune diseases reveals novel single-disease and cross-phenotype associations (2018) (0)
Cranial and extracranial giant cell arteritis do not exhibit differences in the IL6 -174 G/C gene polymorphism. (2022) (0)
J.L. Fernández-Sueiro 1 , (2004) (0)
Meta-analysis of Immunochip data of four autoimmune diseases reveals novel single-disease and cross-phenotype associations (2018) (0)
[Calcinosis. Limited systemic sclerosis (CREST syndrome)]. (2009) (0)
THU0150 INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. WHAT DO WE DON’T KNOW? THE LIRA STUDY (LUNG INVOLVEMENT IN RHEUMATOID ARTHRITIS). (2020) (0)
Meta-analysis of Immunochip data of four autoimmune diseases reveals novel single-disease and cross-phenotype associations (2018) (0)
Therapeutic update in large vessel vasculitides (2013) (0)
P247 Carotid Plaque Assessment reclassifies patients with Inflammatory Bowel Disease into Very-High Cardiovascular Risk (2021) (0)
Pleural and Pericardial Effusion as the Only Manifestation of IgG4-Related Disease. (2020) (0)
Performance of Cardiovascular Risk Age and Vascular Age Estimations in Predicting Cardiovascular Events in Rheumatoid Arthritis (2017) (0)
SAT0016 Role of PCR, GCKR, HNF1A, LEPR, ASCL1 and NLRP3 in Atherosclerosis in Patients with Rheumatoid Arthritis (2016) (0)
AB0013 Lack of Association between IL6 Gene and Henoch-SchÖNlein Purpura (2014) (0)
[Multiple myeloma, atypical presentation]. (1991) (0)
SAT0109 SMOKING CESSATION IN PATIENTS WITH RA IS ASSOCIATED WITH REDUCED CVD EVENT RATES AND IMPROVED LIPID PROFILES AND PREDICTS LOWER RA DISEASE ACTIVITY (2019) (0)
Disease Activity Is More Associated with IL-1 Than with IL-6 in Patients with Rheumatoid Arthritis (2022) (0)
Acute monoarthritis as presenting manifestation of acute Q fever: report of a new case and literature review. (2013) (0)
AB0586 Short and Long-Term Anti-TNF-Alpha Therapy in Refractory Uveitis. Study of 40 Adult Patients from A Single Universitary Center (2014) (0)
Role of vascular endotelial growth factor polymorphisms in interstitial lung disease (2019) (0)
A Genome-Wide Association Study Identifies Plasminogen and P4HA2 as Novel Susceptibility Genes for Giant Cell Arteritis (2017) (0)
Trial of Tocilizumab in Giant-Cell Arteritis. (2017) (0)
Oral anticoagulant treatment in rheumatoid arthritis patients with atrial fibrillation results of an international audit (2022) (0)
SAT0523 Evolution of visual affection in patients with giant cell arteritis treated with tocilizumab (2018) (0)
Identification of new risk loci shared across systemic vasculitides points towards potential target genes for drug repurposing (2023) (0)
AB0294 THE EFFECT OF SMOKING ON ENDOTHELIN-1 IN PATIENTS WITH RHEUMATOID ARTHRITIS (2019) (0)
Timing of Onset and Cluster with Other Manifestations Influence the Spectrum of Arthritis in Anti Jo-1 Positive Antisynthetase Syndrome: Results from a Multicenter, International, Retrospective Study (2015) (0)
[Ehlers-Danlos's syndrome type II. A family study]. (1992) (0)
FRI0250 SUBCLINICAL ATHEROSCLEROSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS: COMPARABLE EFFECT OF TRADITIONAL CARDIOVASCULAR RISK FACTORS WITH RHEUMATOID ARTHRITIS (2019) (0)
Vascular Endothelial Growth Factor and Its Soluble Receptor in Systemic Lupus Erythematosus Patients (2022) (0)

This paper list is powered by the following services:

Miguel Ángel González‐gay's Academic­Influence.com Rankings

Miguel Ángel González‐gay's Degrees

Similar Degrees You Can Earn

Why Is Miguel Ángel González‐gay Influential?

Miguel Ángel González‐gay's Published Works

Published Works

Miguel Ángel González‐gay's AcademicInfluence.com Rankings